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ABSTRACT 
Herpes B virus, otherwise known as Macacine herpesvirus 1, is a member of the family 
Herpesviridae, subfamily Alphaherpesvirinae, genus Simplex, and is closely related to human 
herpes simplex viruses 1 and 2 (HSV1 and HSV2). B virus is endemic in macaque monkeys, but 
is capable of zoonotic transmission to humans resulting in fatality in greater than 80% of 
untreated cases. The goal of our lab is to understand the disparity in the outcome of infection 
between the natural host- macaques and the foreign host- humans. An important barrier to 
progress is the lack of understanding of host cell: B virus interactions in response to infection.  
An important pathway activated by stress, known as the mitogen activated protein kinase 
(MAPK) p38 pathway, is activated by B virus infection. Of particular interest is its role in 
regulating cellular translation via stimulation of activation of the eukaryotic initiation factor 4E 
(eIF4E). The activation of eIF4E is a vital rate-limiting step in translation, which can be 
manipulated by a variety of viruses. For example HSV1 can activate eIF4E through the p38 
pathway but in the absence of this pathway eIF4E activity and viral titers are decreased. Because 
of the effect HSV1 has on the p38 pathway, and because B virus is a close relative of HSV1, we 
hypothesized that B virus also utilizes the p38 pathway to activate eIF4E in a host-dependent 
manner.  In this dissertation, we show that the role of MAPK p38 with regard to translation is 
crucial to cellular processes that reduce virus replication in natural host cells, but within human 
cells this stress pathway appears not to play a role in reducing B virus replication. Data generated 
for this dissertation suggest that the p38 pathway is responsible in part for controlling the virus 
infection and spread within the natural host, but does not dampen virus replication in human host 
cells encountering the virus. Taken together, our results suggest that this pathway has at least one 
host-specific defense to combat B virus infection and that both cellular and viral proteins require 
the presence or absence of this pathway to function.   
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1 
1 INTRODUCTION  
1.1 B Virus  
B virus (Macacine herpesvirus 1) is a member of the genus Simplex, the 
Alphaherpesvirinae subfamily, and the family Herpesviridae. Also belonging to the genus 
Simplex are human herpesviruses herpes simplex viruses 1 and 2 (HSV1 and HSV2), with which 
B virus shares great homology. Currently it is the only known herpesvirus endemic in nonhuman 
primates to be pathogenic in human hosts. The transmission of virus from animal to humans is 
known as zoonosis. Monkeys belonging to the genus Macaca are the natural hosts for this virus. 
Although transmission of the virus from animals to humans is rare, the mortality rate of a 
zoonotic infection is greater than 70% in the absence of antiviral treatments administered early in 
infection.  
The first reported case of a zoonotic B virus infection occurred in 1932 when a physician 
researcher named William Brebner was bitten on the hand by a seemingly healthy rhesus 
macaque (Macaca mulatta). Young Dr. Brebner developed encephalomyelitis and succumbed to 
the disease approximately two weeks after the exposure event. Samples were obtained from this 
patient and tested on rabbits by Drs Gay, Holden, and Sabin, which resulted in similar disease 
progression. The virus was characterized as a herpesvirus and named B virus in memory of Dr. 
Brebner [1, 2]. 
1.1.1  Virus Structure and Life Cycle 
B virus has a large, double stranded DNA genome with a high G+C content 
(approximately 75%), making it the simplex virus with the highest G+C content [3]. High G+C 
content is associated with greater DNA stability due to the presence of three hydrogen bonds 
between guanine and cytosine residues as opposed to the presence of just two hydrogen bonds 
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between adenine and thymine residues within the chain structure. Our laboratory has shown that 
the total genome length is approximately 156,789 bp and is organized in a manner characteristic 
of a simplex genome. There are six origins of DNA replication (ori regions) resulting from 
tandem duplication of the oriS and the oriL regions. Seventy-four genes have been identified, all 
of which, except one, show homology with the corresponding genes in related human herpes 
simplexviruses [4]. The core of the virus particle is electron dense and is surrounded by an 
icosapentahedral capsid with a tegument protein layer and a lipid envelope [5]. There are eleven 
glycoproteins attached to the lipid envelope that facilitate attachment and entry of the virus 
particle into the cell [4].  
Like most other alphaherpesviruses, B virus infects mucosal epithelia and undergoes 
multiple rounds of replication in the epithelial cells. There are three classes of genes transcribed 
during replication that are separated by function and time of appearance post infection. The first 
class of genes is known as the immediate-early or alpha (α) genes, the second class consists of 
the early or beta (β) genes, and the last class of genes is the late/true-late or gamma/gamma1 
(γ/γ1) genes. Infected cells eventually release new virus progeny to spread through the 
surrounding areas. The virus then makes its way to the sensory nerve endings where it is 
transferred retrograde to the nuclei in cell bodies of sensory neurons in the peripheral nervous 
system (PNS) [6]. Virus can also spread via syncytia formation directly from cell to cell without 
coming into contact with the extracellular environment, suggesting that innate cellular defenses 
need to exert their respective defensive reactions if the virus can escape antibodies. The virus can 
establish latency in the sensory neurons where it will be limited virus transcription of latency 
associated transcripts (LATs) and replication. Rarely does the virus travel past this site to enter 
the spinal cord or brain. Periodically, reactivation can occur throughout the lifetime of the host 
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during which time the virus will travel anterograde through the axons of sensory neurons to the 
dermal cells where the virions undergo replication and repeat the cycle as before. Infectious virus 
may then be released through the mucosa and accompanying bodily fluids [7]. 
In Vero cells (African green monkey kidney cells) culture, high multiplicity B virus 
infection shows a typical replication cycle characteristic of herpesviruses. There is an initial 
decrease in extracellular plaque forming units (PFUs) after addition of the virus. Intracellular 
virus is shown to increase six hours post infection (hpi.) and assembled virions increase in 
numbers through twenty-four hpi, with adjacent cells becoming infected and repeating the 
process over and over again whether in cell culture or in vivo, the latter until host defenses limit 
further advance.  Extracellular virus progeny also increase in numbers around six hpi into each 
replication round, but remain relatively low (at approximately 10% of the total virus produced) 
for the remainder of the life cycle. Viral titers, both intra- and extracellular, begin to plateau 
between twenty-four and thirty-six hours hpi in cell culture. [8]. 
1.1.2  B virus infection in the natural host: the macaque monkey 
B virus has been isolated from a variety of macaque monkeys like the stumptail, pig-
tailed, Japanese, bonnet, and Taiwan macaques; however, the most commonly studied macaques 
are the cynomolgus and rhesus macaques (M. facicularis and M. mulatta) each used frequently in 
biomedical research [9]. There is an 80-100% seropositivity rate in adult macaques in captive 
populations that have not undergone a process to derive B virus-free offspring [10]. Macaques 
are usually asymptomatic, but if they are stressed or immunocompromised in any way they can 
exhibit herpetic lesions at mucosal sites, such as the mouth, eyes, and genitalia. Genital lesions 
are rarer though genital infections do occur [11, 12]. Macaques are more likely to shed virus 
during breeding season, immunosuppression, or primary infection [9, 10, 13]. 
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1.1.3 Deadly B virus infection in the foreign host: the human 
Zoonotic infection of humans with B virus usually occurs via direct contact with 
macaques or their infected bodily fluids. Infection usually occurs through bites or scratches that 
break the skin or by contact of the mucosa with infected bodily fluids or tissue [9, 14]. Indirect 
contact with a contaminated object can also result in zoonotic transmission and a human-to-
human transmission event has occurred in one instance by sharing a tube of ointment that was 
being used to treat a bite on a spouse who was unknowingly infected with B virus [14]. Once 
infected there is an incubation period of anywhere from a few days to weeks, although in some 
cases months-to-years go by before infection becomes evident. It is widely believed that disease 
progression is dependent upon the site of the primary infection and the amount of virus that was 
introduced into the wound [9, 15, 16]. Apparent disease begins with flu-like symptoms like 
fever, fatigue, muscle aches, and headaches. Other symptoms that occur in some patients include 
lymphadenitis, nausea, vomiting, and abdominal pain. While in healthy macaques the virus stays 
predominantly within the PNS, in human hosts B virus eventually progresses to the central 
nervous system (CNS). Once the CNS has been breached, neurologic ailments begin to present 
such as hyperesthesias, ataxia, diplopia, agitation, and ascending flaccid paralysis depending on 
the region of brain or spinal cord affected [9, 14-16]. Most patients succumb to the infection 
once the virus reaches the CNS even with antiviral therapy and supportive care. These deaths are 
usually caused by respiratory failure that accompanies the ascending paralysis. The patients that 
survive are left with varying degrees of neurologic ailments. Latency and reactivation are also 
characteristics of zoonotic infection of humans, therefore patients must be vigilant in taking daily 
antiviral medications to prevent a reactivation, which is just as dangerous as the initial infection 
[17].  
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1.1.4 B virus as a threat both inside and outside the laboratory 
Macaque monkeys are a invaluable resource in biomedical research as they are the best 
model for HIV infection because of the similarities between HIV and simian immunodeficiency 
virus (SIV) derived from sooty mangabys. Because of the use of macaques in research studies 
and intensive breeding practices to supply greater numbers of animals, the number of zoonotic 
infections of humans with B virus has increased since the initial use of macaques in research 
models [18]. The greatest clusters of zoonotic infection prior to the present time occurred during 
the production of the polio vaccine in the 1950’s and 1960’s.  Zoonosis occurs when an endemic 
or natural host pathogen that controls the virus, in this case B virus in macaques, jumps as a 
result of close contact to invade a similar yet unfamiliar host, the human. Zoonosis implies that a 
human has become infected by an animal virus.. These barrier breaches usually occur between 
species that are closely related; however, transmission barriers can be either inherently low or 
artificially lowered. For example, humans coming into contact with exotic animals at zoos or 
parks, pets living in the same space as their owners, and more recently the development of 
xenotransplantation wherein animal organs are transplanted into humans [19].  
The majority of viruses burdening the human population today originated in animals and 
include influenza viruses, human immunodeficiency virus -1 (HIV-1), dengue, and Nipah viruses 
[20]. Some herpesviruses have been associated with zoonotic potential such as pseudorabies 
virus and equid herpesvirus (EHV-1). EHV-1 has been shown to infect a variety of cells from 
different hosts, with human epithelial cells being among them. Zoonotic potential is an important 
consideration with the growing development of xenotransplantation in the medical world. One of 
the major barriers to progress in using xenogenic organs for transplants is the transmission of 
viruses from the donor animal organ to the transplant recipient [19].  
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There are three stages leading to successful transfer of viral disease to a new host: (I) 
initial single infection of new host with no subsequent infection, (II) subsequent infections that 
cause local chains of transmission in the new host population, and (III) epidemic or sustained 
endemic host-to-host transmission in the new host. During stage I, a crucial step in determining 
host specificity is the initial interaction between the virus and the cells encountered by the virus. 
Changes in entry receptors, as well as intracellular defenses, determine if the foreign host will be 
successfully infected [20].   
Though B virus does not currently present risks in the world of xenotransplantation, it 
does present a clear and present danger of zoonotic transmission to the handlers and researchers 
that interact with macaques, to tourists visiting endemic areas, to zoo keepers and sanctuaries, 
and to individuals who choose to treat macaques as pets. To make matters more difficult, 
reactivation and shedding of B virus in macaques is difficult to detect, therefore animals that are 
seropositive, but asymptomatic, present the threat of zoonotic infection to individuals in close 
contact with the macaques. The National Institutes of Health’s National Center for Research 
Resources initiated funding for the development of specific pathogen-free (SPF) colonies of 
macaques for research purposes in 1989; however, SPF status does not necessarily mean these 
animals are not infected since there is difficulty detecting the virus and/or antibodies against the 
virus in animals that are not undergoing a primary infection, or reactivating with shedding.   
Asymptomatic macaques also present a challenging problem [18, 21].  
Based on all of this information, it is important to understand how zoonotic viruses 
interact differently with their foreign and natural host cells representative of those targeted at the 
time of virus entry, and how these interactions contribute to different host responses. Zoonotic 
potential is also an important factor to consider when selecting an animal model to study human 
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diseases. Using models like the macaque, one if not the most popular non-human primate model 
puts researchers and animal handlers at increased risk of contracting infectious agents, usually 
when in close contact with them. Using an innovative approach to the study of how zoonotic 
infections progress differently in their foreign and natural hosts, we developed a model of B 
virus infection of human and macaque fibroblasts, representative of cells encountered upon virus 
entry, to investigate the modulation of a signaling pathway mediated by the mitogen activated 
protein kinase (MAPK) p38 that results in translation of proteins [22]. The results of these 
experiments provides a better understanding of cellular signaling pathways that are activated as a 
result of virus directly or indirectly, how B virus has selected counterattacks over millennia to 
neutralize these cell defenses, and how humans, in the absence of co-evolving with B virus 
activate cellular defenses to counter virus infection. B virus is a Risk Group 4 pathogen and these 
types of pathogens often find the human a dead-end host, i.e., not a hospitable host that facilitates 
spread of the virus throughout a population, but one which most often loses the battle with the 
virus. 
 
1.2 Importance of cellular signaling pathways  
 Cells must survey changes in their surroundings constantly and rapidly and they do this 
by the reception and transmission of signals that allow them to respond accordingly to the 
changes. There is no sensor superior to cells in this regard.  Reception and transmission of 
signals ignite cell signaling cascades that have evolved as first line innate defenses and respond 
to stimuli in an autocrine and/or paracrine fashion. These cascades rely on post-translational 
modifications of which phosphorylation is the most common. Phosphorylation occurs via 
kinases, of which there are approximately 518 known to exist in human cells [23]. 
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1.2.1 Stress Pathways: Mitogen Activated Protein Kinase (MAPK) p38 
Mitogen activated protein kinases (MAPKs) are the most common kinases in signal 
transduction pathways and are highly conserved. There are many MAPKs responsible for a 
variety of cellular responses to events both intra- and extracellular in nature. The cascades begin 
with the MAPKKKs (MAP3Ks) that are in close proximity to membrane bound receptors and 
other proteins. These MAP3Ks phosphorylate a variety of MAPKKs (MAP2Ks/MKKs), 
depending on the type of stimulus received by the cell. The cascade ends with the terminal 
kinase, the MAPK. The regulation of these kinases depends on their phosphorylation and 
subsequent dephosphorylation of specific amino acid residues within selected proteins. There are 
fourteen known MAP3K isoforms and seven known MAP2K isoforms. These MAPKs can be 
regulated by either MAP kinase phosphatases (MKP) or dual-specificity phosphatases (DUSP). 
There are four sub-families belonging to the MAPKs: extracellular signal-related kinase 1/2 
(ERK1/2), extracellular signal-related kinase 5 (ERK5), MAPK p38, and Jun N-terminal kinase 
(JNK). The MAPK p38 and JNK pathways are considered to be stress-activated protein kinases, 
and are therefore also notated as the SAPK pathways. They are called as such because their 
activation is triggered by cellular and environmental stresses, inflammation, DNA damage, and 
bacterial or viral infection [24]. The focus of the studies outlined in this dissertation is the 
MAPK p38 activated pathways. Currently, there are four known isoforms of p38: p38 
(MAPK14) [25], p38 (MAPK11) [26], p38 (SAPK (stress-activated protein kinase) 3, ERK 
(extracellular-signal-related kinase) 6 or MAPK12 [27], and p38 (SAPK4 or MAPK13) [28]. 
These isoforms are all encoded by different genes and are expressed in different tissues, but with 
a degree of functional redundancy [29]. The pathway is activated by MAP3K, of which there are 
three: MTK1, ASK1, and TAK1. Each then phosphorylates the MAP2Ks [30]. Canonically, 
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MAPKs are dually phosphorylated by MAPK-kinases or MKKs. Of these, MKKs 3 and/or 6 
phosphorylate the various MAPK p38 isoforms in the Thr-Gly-Tyr (threonine-glycine-tyrosine) 
activation loop [31, 32].  Marasa et al.discovered that MAPK p38α can also be phosphorylated 
by MKK4, which has been shown to increase in senescent human fibroblasts via specialized 
translation targeted by four microRNAs [33]. MAPK p38 phosphorylates a variety, estimated 
between 200-300, of proteins both in vitro and in vivo [23]. Because of the variety of proteins 
that can regulate p38 and that can be regulated by p38, this pathway represents a place where 
multiple stimulants such as cellular stress, infection, and inflammation converge and trigger 
different responses that reflect what is perceived as best to protect the cell or the host. 
Interestingly, many viruses that have long infected specific hosts have selected mechanisms by 
which they can thwart the host defenses at this stage of encounter. 
1.2.2 MAPK p38 and downstream effectors 
While other MAPKs such as extracellular-stimulated kinase (ERKs) are not associated 
with stress events, stressful stimuli such as bacterial or viral infection induce constantly high 
levels of MAPK p38 activation, unlike normal circumstances wherein p38 activation occurs at 
lower levels transiently [34]. The first role of MAPK p38 that was discovered was its ability to 
regulate pro-inflammatory cytokine synthesis in endotoxin-stimulated monocytes [35]. 
Kontoyiannis and colleagues demonstrated that MAPK p38α regulates protein translation in 
TNFα protein production. The gene encoding TNFα possesses an AU-rich element (ARE) found 
in the 3’-untranslated region (UTR) that when suppressed, leads to inhibition of p38α-mediated 
TNFα translation [36]. Among other proteins, MAPK p38 also activates several kinases involved 
in gene expression such as MSK1/2, MK2/3, and MNK1/2 that are in part responsible for protein 
translation regulation via the phosphorylation and activation of eIF4E [37, 38]. 
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1.2.3 MAPK p38 and translation 
As previously mentioned p38 phosphorylates a number of downstream effectors, which 
are grouped into a family of proteins called the MAPK-activated protein kinase (MAPKAPK) 
family. There are four subclasses of MAPKAPKs: RSK, MK, MNK, and MSK. RSKs are 
specifically activated by ERK and MKs are specifically activated by p38; however, MNKs 
(MNK1 and MNK2) and MSKs (MSK1 and MSK2) can be activated by both ERK and p38 [39]. 
MNK1 and MNK2 are phosphorylated on Thr197 and Thr202 residues. Studies have shown that 
MNK1 is inducible by growth factors, stress events, and inflammatory cytokines whereas 
MNK2, which is subdivided into proteins MNK2a and MNK2b is not as affected by MAPK 
activity. This is because MNK2a and 2b are spliced variants of the same gene wherein one 
possesses the MAPK binding domain (MNK2a) while the other does not (MNK2b) [39-41]. The 
MNKs are thought to regulate translation of cellular proteins by phosphorylating the eukaryotic 
initiation factor 4E (eIF4E) on serine 209 [40, 42]. The initiation factor eIF4E is known as the 
“cap-binding protein” and binds to the 5’-m7GpppN cap structure on all eukaryotic messenger 
RNA (mRNA). This is a critical function for cap-dependent translation. Activated eIF4E 
participates in cellular translation as a member of the eIF4F complex along with eIF4G, which is 
a scaffolding protein, and eIF4A, which is an RNA helicase. Additionally, a poly adenylate-
binding protein (PABP) binds the 3’-end of the mRNA as well as eIF4G to form a closed circuit 
with the mRNA. This is a checkpoint to ensure the mRNA is intact and functional. This complex 
facilitates the translation initiation by recruiting other proteins to the mRNA such as eIF3, and 
the 40S ribosomal subunit [43]. Regulation of eIF4E phosphorylation is, in part, managed by 4E-
binding proteins or 4E-BP that binds to eIF4E and prevents it from binding to eIF4G. Gingras et 
al.reported that this in turn prevents eIF4E phosphorylation by sequestering it from the eIF4F 
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complex and ultimately MNK. They also showed that 4E-BPs can be hyperphosphorylated and 
inactivated by mammalian target of rapamycin (mTOR) and this allows eIF4E to bind to the 
eIF4F complex and subsequently interact with MNK to become phosphorylated [44]. Depending 
on the signaling context, either ERK or p38 may phosphorylate MNK1. When stimulated by 
growth factors or phorbol esters, ERK is predominantly the MAPK responsible for MNK1 
phosphorylation; however, when cells are stimulated by stress events such as bacterial or viral 
infections or inflammatory cytokine production, p38 becomes the predominant phosphorylating 
kinase of MNK1 [42]. 
1.2.4 Viral Infection and Cellular Translation 
Because viruses require materials and energy of host cells to replicate, they first target 
cells that are metabolically active. Viruses must recruit cellular ribosomes to translate viral 
mRNA into protein products needed to further their replication process, assembly, and egress. To 
use the cellular machinery, viruses often find ways to down-regulate cellular defenses that may 
thwart the infection process. They target every step of translation – initiation, elongation and 
termination – to take control of the host translational machinery as reviewed by Walsh and 
colleagues [45].  Herpes simplex virus 1 (HSV1) indirectly manipulates translation factors by 
preventing PABP recruitment to the eIF4F complex, which is thought to contribute to host shut-
off that occurs early in infection, but restarts as infection progresses [46]. HSV1 is also capable 
of controlling translation by manipulating the host and viral mRNA. The DNA viruses that 
produce capped mRNAs with poly-adenylated tails such as poxviruses and herpesviruses have 
de-capping enzymes that destabilize host mRNAs upon virus entry [47]. It has long been known 
that HSV1 encodes a gene known as the host shut-off gene (vhs) that interacts with eIF4A and 
other initiation factors to increase the translation rate of both host and viral mRNAs [48] not a 
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primary reference but you can edit to say as described by Feng et al. Also long appreciated is that 
HSV1 also encodes infected cell protein 27 (ICP27), which inhibits host mRNA splicing and 
transport to the cytoplasm while simultaneously promoting viral mRNA export from the nucleus 
to the cytoplasm [49]. HSV1 also stimulates the phosphorylation of eIF4E as well as 4E-BP1 and 
promotes the assembly of the eIF4F complex via ICP0. When cells are treated with the p38 
inhibitor SB203580, eIF4E phosphorylation via MNK1 is visibly down-regulated in western blot 
assays. Viral replication is also reduced in p38-inhibited cells, which suggests that 
phosphorylation of eIF4E by MNK1 is critical for HSV-1 protein synthesis [50]. In conclusion, 
HSV1, a close relative of B virus, is capable of suppressing and enhancing translation for the 
purpose of successful translation of viral proteins.  It was logical to suspect that stress pathways 
in human cells may not have the advantages of those in macaque cells since macaques and B 
virus have co-evolved together for millennia and can co-exist peacefully, an advantage for both 
the virus and the host. 
1.3 Summary 
In summary, cells activate or inhibit a number of intracellular signaling pathways when 
the presence of a virus is sensed, one of which is the MAPK p38 pathway. Cells infected with 
alphaherpesviruses are capable of activating this cellular pathway as is evidenced by the studies 
done with HSV1 and its affect on p38 and downstream effectors, but little is known about the 
role of this pathway in the context of translation during B virus infection in the natural and 
foreign hosts following virus entry. This lack of knowledge presents a critical barrier to the 
progress of engineering antiviral interventions.  Previous work in our lab determined that B virus 
induces specific innate immune responses when it enters the site of primary infection, viz., the 
epidermal and dermal layers of skin or mucosa, and these responses affect viral replication and 
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some lead to subsequent cytokine and chemokine production. To accomplish this, a comparative 
model system was developed by our laboratory using primary human foreskin fibroblasts 
representative of cells found at the initial site of infection in humans, and primary rhesus 
macaque fibroblasts, a previously unavailable, established in our laboratory through the tissue 
sharing program at the Yerkes National Primate Research Center.  These two primary cell lines 
allowed for the first time the studies described in this dissertation. The MAPK pathways were 
targeted to study the overarching hypothesis of this dissertation because these pathways are 
multifunctional and are critical for cells to respond to stress, induce apoptosis for the greater 
good of the host, and generate inflammatory responses to recruit more extensive adaptive 
defenses [22]. When dermal cells become infected with HSV1 MAPKs are also activated,[51]. 
As previously discussed it is well known that viruses depend on host cell machinery to translate 
viral mRNA into protein products that enable replication and subsequent production of virus 
progeny. It is also established that the MAPK p38 pathway contributes to phosphorylation of 
eIF4E, the cap binding protein necessary for cap-dependent translation, and finally that 
herpesviruses are capable of regulating this pathway to benefit viral replication and protein 
production. The focus of this study was to investigate the role of p38 in the context of viral 
replication in the macaque and human at the primary infection site and how inhibiting this 
pathway changes viral replication and phosphorylation events of cellular translation machinery. 
We hypothesized that p38 regulates eIF4E phosphorylation to modulate B virus replication in 
macaques; particularly at the initial site of infection and that human cells lack this evolutionary 
advantage.  
The following specific aims were designed to test this hypothesis: 
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Aim 1: Test the hypothesis that eIF4E phosphorylation and virus replication 
depends on p38 activation during B virus infection in macaques and humans 
 
 
Aim 2: Test the hypothesis that interactions between B virus proteins ICP6 and Us3 
and cellular translation proteins are regulated by p38 during B virus infection in macaque 
and human cells, representative of those found at the site of infection. 
2 AIM 1: TEST THE HYPOTHESIS THAT eIF4E PHOSPHORYLATION AND 
VIRUS REPLICATION DEPEND ON P38 DURING B VIRUS INFECTION  
 Phosphorylated p38 subsequently phosphorylates MAP kinase-activated protein kinase 
(MNK1), which in turn phosphorylates eIF4E and our data indicate that B virus does not 
interfere with this stress response in either macaque or human cells.  Once phosphorylated, 
eIF4E is able to bind to the 5’-cap of mRNA awaiting translation. After phosphorylation eIF4E 
becomes part of the eIF4F complex with eIF4G, a scaffolding protein, and eIF4A, an RNA 
helicase. This complex associates with the ribosome for translation to occur [52]. While some 
viruses inhibit this process, HSV-1, a close relative to B virus, drives eIF4F complex formation 
[50]. The experiments proposed to accomplish this aim are designed to determine if B virus 
regulates eIF4E phosphorylation via p38 activation and if this regulation differs between human 
and macaque fibroblasts.   
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2.1 Kinetics of MAPK p38 activation and associated protein phosphorylation for 
translation of mRNAs during B virus infection of cells representative of those initially 
infected in dermal and mucosal sites of macaques and humans. 
The first experimental designs were conceived to identify at what point through 24 hours 
of B virus infection that p38 phosphorylation was highest, reflecting activation of cell stress 
pathways. Thus timecourse infections were performed at multiple independent times wherein 
human foreskin fibroblasts (HFF) and rhesus macaque fibroblasts (RMF) cells were infected 
with B virus using sufficient amounts of virus to uniformly infect the vast majority of cells used 
and at various times post infection, the infected cell lysates were collected for analyses. These 
lysates were electrophoretically fractionated using SDS-PAGE in order to transfer lysate proteins 
to nitrocellulose membranes to assess the relative amounts of p38 phosphorylation at different 
times following infection. Fibroblasts from each host were chosen as these cells make up a large 
portion of the cells within the dermal layer of the skin and are closest to the sensory nerve 
endings that ultimately become infected. In the event of a bite or scratch these cells would be 
among the first infected by B virus. The HFF were purchased from ATCC and, at the time there 
were no commercially available macaque fibroblasts, so we developed a protocol to isolate 
fibroblasts from necropsy samples taken from macaque monkeys. The tissues were generously 
provided by Yerkes Primate Research Center as part of their tissue-sharing program.  
The goal of the initial experiments was not only to observe the phosphorylation and 
expression pattern of p38, but also the phosphorylation and expression pattern or eIF4E 
throughout 24 hours of B virus infection in macaque and human fibroblasts. During the first 
rounds of virus replication, host cells initiate innate responses that engage defenses that evolve to 
protect the host. Infection was done with a multiplicity of infection (MOI) 5, meaning that the 
16 
cells in the monolayer culture were exposed to approximately five plaque forming units (PFU) 
per ml of solution, i.e., at least five replication competent virions per cells, ensuring that 90-96% 
of the cells become infected at nearly the same time. This was necessary to ascertain when in the 
viral life cycle protein expression and phosphorylation of p38 and eIF4E would be at their 
highest and lowest, undiluted by cells that are not infected. The results obtained from these 
kinetic studies were used to determine at which time post infection the inhibition studies outlined 
later in this section would take place. 
For the first time, as a result of these initial experiments our data revealed that 
phosphorylation of p38 occurs throughout B virus infection in both HFF and RMF. We 
discovered levels of phosphorylated p38 were significantly higher in infected HFF and RMF 
than in uninfected cells at the later times post infection, specifically at 18 and 24 hours post 
infection (FIG 1).  Levels of phosphorylated p38 in RMF were slightly less elevated when 
compared to levels of the same in HFF cells, though not significantly, suggesting that B virus 
activates the MAPK p38 stress pathway nearly equally in both macaque and humans cells 
representative of the cells initially infected upon virus entry.  The presence of phosphorylated 
p38 in uninfected cells confirmed that basal levels are needed for normal cellular activity. The 
increase of phosphorylated p38 late in the replication cycle suggests that the cells’ response may 
be to control the infection by engaging stress responses, which would in turn activate several 
transcription factors involved in both pro- and anti-inflammatory responses. Alternatively, B 
virus may exploit this pathway for virus replication.  To determine which scenario is taking place 
during B virus infection, experiments were designed to validate whether the predicted pathways 
were initiated following phosphorylation of p38. 
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The activation of the MAPK p38 pathway ultimately leads to the phosphorylation of the 
translational-critical eIF4E molecule, which is one of the regulators of whether capped mRNA 
from virus and/or cells is translated. Because eIF4E is a downstream effector of phosphorylated 
p38, I predicted eIF4E phosphorylation increases during B virus infection in HFF and RMF since 
p38 phosphorylation indeed increases between 18 and 24 hours post infection.  The data from 
experiments designed to test this demonstrated that phosphorylation of eIF4E occurred 
throughout infection, but did not significantly increase during B virus infection in macaque or 
humans cells, when compared to levels observed in uninfected cells in spite of the increased 
levels of phosphorylated p38. These data may suggest that the virus can use constitutive levels of 
phosphorylated eIF4E to replicate, or alternatively, that the presence of eIF4E activity does not 
threaten B virus replication, thus there is no apparent need for the virus to have evolutionarily 
selected a countermeasure to block or reduce the levels of phosphorylated eIF4E (FIG 2).  
Because phosphorylation of p38 did not significantly increase until 18-24 hours post 
infection, I determined that 24 hours post B virus infection in HFF and RMF would be an 
appropriate timepoint to sample for the next experiments.  These experiments were designed to 
understand what would happen in each cell type to the progression of B virus infection if 
phosphorylation of p38 was blocked.  This block would reduce or eliminate the increased 
activation seen late in infection and provide insight into the relevance of p38 phosphorylation 
and thus address whether eIF4E phosphorylation was critical to B virus replication in each cell 
type.  To address this question the experiments described in 2.2 were designed.  
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2.2      Verification of p38 inhibition with SB203580 treatment of HFF and RMF during B 
virus infection. 
Our data show for the first time that during B virus infection of macaque and human cells 
phosphorylation of p38 is significantly increased at 24 hours post infection. Inhibition of p38 
phosphorylation at the onset of B virus infection then would alter the course of virus replication 
if this stress pathway serves an effective cell defense. The question posed is what happens during 
the initial round of virus replication if MAPK p38 stress responses cannot engage. To analyze 
this we added the chemical inhibitor SB203580 (600 nM) to HFF and RMF prior to, during, and 
after infection. Chemical inhibitors such as the pyridinyl-imidazole drug SB203580 have been 
successfully used to study ablation of p38 activation. This drug competitively binds to the ATP-
binding pocket to block phosphorylation of p38α and p38β, but not p38γ or p38δ [53]. The 
inhibition via SB203580 relies on interaction with the amino acids near or inside of the ATP-
binding pocket, specifically with Thr106 of p38α and p38β [53, 54]. In previous experiments 
(Figure 1), we see a basal level of p38 phosphorylation in uninfected and mock-infected cells 
indicating that the serum in the media is stimulating phosphorylation of p38. For this reason, 
prior to treatment and infection, cells were serum starved for 18-24 hours to essentially 
synchronize cells at the G0-G1 interface so that all cells would be at nearly the same place in their 
cell cycle at the time virus was added. This was to ensure that any observed event was triggered 
by the presence of virus and/or activation of p38, and not driven by the presence of serum within 
the medium. In uninfected and mock-infected cell lysate (MCL)-treated HFF, our data 
demonstrate that no p38 phosphorylation occurs. These data indicate that p38 was not activated 
and therefore neither the serum starvation, nor the presence of uninfected VERO cell lysate has 
triggered a stress response. The MCL treatment group was a necessary control because the B 
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virus stock used in these experiments was prepared by first infecting VERO cells, then lysing 
them to release virus particles. Therefore, MCL is representative of the addition VERO cell 
lysate along with B virus being applied to the cellular monolayer during infection, but for MCL 
without the presence of virus. In HFF and RMF infected with B virus, we see a marked 
expression of phosphorylated p38, indicating that B virus has triggered a stress response within 
the cells, thus there was no difference between macaque and human skin cells at this stage of 
infection. We observed significant reduction in phosphorylation of p38 in BV infected cells 
treated with SB203580 when compared with cells infected with BV in both HFF and RMF in the 
presence of p-p38, validating that SB203580 effectively decreased p-p38 levels (FIG 3). 
Because of the reversible properties of the inhibitor, complete reduction was difficult. Chemical 
inhibitors are often useful in scientific research when studying the effect of a certain protein 
within a system. When the activity of that protein is effectively reduced or inhibited, we can 
determine how the system responds to the absence of that particular protein, and or the 
subsequent pathways engaged, and from that we can surmise the role of a specific cellular 
protein during virus replication.  
This experiment demonstrated that we successfully reduced and even eliminated 
phosphorylation of p38 in both HFF and RMF 24 hours post B virus infection. It was now 
possible to initiate experiments to investigate the effects of p-p38 on other factors, particularly 
those involved in translation of viral and cellular mRNA in HFF and RMF during B virus 
infection. We designed experiments to test whether p-p38 was critical for eIF4E 
phosphorylation, anticipating that in the absence of activating the MAPK p38 pathway, mRNA 
translation would be restricted to existing basal levels of p-p38. Recall that data from previous 
experiments demonstrated that eIF4E phosphorylation was not significantly upregulated or 
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down-regulated during B virus infection in either cell species. To see if p-p38 plays a role in 
maintaining the steady-state of eIF4E phosphorylation, we analyzed phosphorylation levels of 
eIF4E in the presence and absence of p-p38 during B virus infection in cells from each species, 
macaque and human.  
2.2 Inhibition of p38 phosphorylation does not significantly alter eIF4E phosphorylation 
in neither HFF nor RMF during B virus infection. 
Previous studies showed that HSV1 altered translation events either by altering mRNA or 
interaction with translation proteins [50]. Data from Walsh and Mohr demonstrated that HSV1 
requires phosphorylation of eIF4E by MNK1 for replication in human fibroblasts and when these 
fibroblasts are treated with the p38 inhibitor SB203580 viral titers decrease, as does eIF4E 
phosphorylation.  Their data demonstrated that p-p38 is critical for at least part of the viral 
replication cycle, suggesting that HSV1 exploits the stress pathway to enhance virus replication. 
In this case, instead of the pathway proving to be an effective cellular defense, it has been co-
opted by the virus to increase virus replication. Because the process of HSV1 replication has 
successfully exploited a cell defense, an appropriate candidate protein to analyze is the 5’-end 
cap-binding protein eIF4E, which is a translation initiation factor downstream of p-p38 activity. 
When activated, p38 phosphorylates eIF4E kinase MNK1, which in turn phosphorylates eIF4E 
[23, 52]. Because eIF4E is a crucial part of the translational processes, we designed experiments 
to determine if B virus exploits p-p38 to modulate virus replication in the macaque host, but 
perhaps not in the human host via phosphorylation of eIF4E.  
From these experiments our data revealed no change in phosphorylated eIF4E when the 
MAPK p38 pathway activation was inhibited compared with samples prepared in the presence of 
p38 (FIG 4). This is to say that there was not a significant increase nor was there a significant 
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decrease. If p38 phosphorylation leads to the subsequent phosphorylation of eIF4E, then 
inhibiting p38 activity should have decreased eIF4E phosphorylation; however, this was not 
observed. This data suggests that either eIF4E phosphorylation is not affected by p38 activity or 
that another protein, either cellular or viral in nature, is aiding in maintaining eIF4E activity in 
the absence of p38. Though MNK is the only known cellular protein responsible for 
phosphorylating eIF4E, there is another MAPK that is capable of phosphorylating MNK. 
Extracellular signal-related kinase (ERK) is a MAPK stimulated by non-stressful stimuli such as 
hormones, growth factors, etc. and also phosphorylates MNK. For this reason, we thought it 
necessary to test the hypothesis that ERK was phosphorylating MNK in the absence of p38. 
2.3 ERK is phosphorylated at early times post B virus infection, but is not 
phosphorylated at late times post B virus infection in HFF and RMF. 
 Extracellular signal-related kinase (ERK) is a MAPK mainly activated by growth factors 
and phorbol esters and is thought to be a key regulator in cell proliferation, whereas p38 is more 
involved in the stress response and is activated by stressful stimuli such as infection, 
inflammatory cytokines, and environmental stress. Despite being activated by different stimuli, 
both MAPKs are capable of phosphorylating MNK1, which in turn phosphorylates eIF4E [55]. 
Because of its potential to phosphorylate MNK1, it is possible that it is also in part responsible 
for MNK1 activation along with p-p38; therefore, we next determined whether or not ERK is 
activated during a B virus infection. Analysis of our data revealed that ERK was phosphorylated 
in both the MCL-treated and B virus infected HFF and RMF cells, indicating that ERK activity is 
not downregulated in the early stages of B virus infection (0-6 hours pi). Until 6 hours post 
infection, we observed robust phosphorylation of ERK in both infected and uninfected cells; 
however, by 18 hours post infection levels of ERK phosphorylation decreased significantly in B 
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virus infected cells indicating that stress responses have been initiated and non-stress related 
pathways shutting down. By 24 hours post infection, ERK phosphorylation is almost completely 
gone in both cell types. At this time post infection, the cytopathic effect (CPE) of the B virus 
infection has increased to 4+ with syncytia formation, blebbing, and cell lysis. These data 
indicated that most cells were dying or undergoing apoptosis in an effort to stunt the spread of 
virus (FIG 5). These results were predicted because ERK is not a MAPK that usually 
participates in stress responses. These data suggests that at early times post infection, the 
infection is somewhat under control or has not caused sufficient damage to warrant a stress 
response. Alternatively, specific viral proteins may interfere with the activation of the stress 
responses associated with the MAPK p38. By 18h and 24h post infection, the virus has caused 
enough damage to induce the cellular stress responses and either directly or indirectly also 
decreased activity of non-stress associated pathways. Once we determined that ERK is not 
activated at late times post infection, we tested the hypothesis that ERK is phosphorylated during 
B virus infection in the absence of p38. 
2.4 MAPK p38-independent phosphorylation status of ERK in B virus infected HFF and 
RMF at 24h p.i. 
Literature suggests that MNK1 is activated only by p38 or ERK. [55]. So far we have 
shown that p38 phosphorylation is significantly increased during B virus infection and that ERK 
phosphorylation is significantly decreased during B virus infection, each observed particularly at 
late times post infection. In the absence of p-p38, p-ERK levels are down-regulated in human 
cells infected with HSV1, but it is possible that p-ERK could still phosphorylate MNK1, which 
in turn phosphorylates eIF4E to allow viral mRNA translation to proceed during B virus 
infection independently of p-p38 [56]. In our experiments, we observed that ERK 
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phosphorylation is apparent in untreated and MCL-treated HFF and RMF, which confirms the 
findings shown in Fig 5. ERK is not phosphorylated during B virus infection in the presence or 
absence of p-p38 activity in HFF and RMF (FIG 6). These data indicate that ERK 
phosphorylation occurs independently of p-p38 and is not responsible for maintaining eIF4E 
phosphorylation during B virus infection in the absence of p38. These data suggested that there is 
some other protein that is stabilizing eIF4E activity, raising the possibility that another cellular 
protein(s) or a viral protein may ensure the presence of p-eIF4E. The latter possibility will be 
addressed in the experiments designed to accomplish the second aim of this dissertation. Thus, 
our next question at this point in the designed studies was whether or not a negative regulator of 
eIF4E, 4E-BP1, was being regulated by p-p38 activity during B virus infection in each cell type. 
Because eIF4E phosphorylation does not require p-p38 activity in either cell types, we designed 
experiments to investigate eIF4E regulation via other cellular mechanisms. Having evaluated 
possible positive regulators, p38 and ERK, it was time to look at potential negative regulators. 
2.5 MAPK p38 is critical for phosphorylation of 4E-BP1 in RMF, but does not affect 
phosphorylation of 4E-BP1 in HFF: A critical species divergence during B virus 
infection 
Numerous investigations in multiple laboratories have shown that phosphorylation of 
eIF4E is inhibited by the 4E-binding proteins (4E-BP). When hypophosphorylated, 4E-BP1 
binds to eIF4E, it prevents eIF4E association with eIF4G. Upon activation, the cellular protein 
mammalian target of rapamycin (mTOR) phosphorylates 4E-BP1, which causes the release of 
eIF4E, allowing the interaction between eIF4E and eIF4G. With eIF4E no longer bound to 4E-
BP1, MNK1 can phosphorylate eIF4E and translation can proceed [50]. Because eIF4E 
phosphorylation occurred independently of p38 activity during B virus infection of macaque and 
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human cells, we designed experiments to evaluate whether or not 4E-BP1 phosphorylation 
requires MAPKp38 activation during infection.  
There are seven known phosphorylation sites on 4E-BP1, five of which are conserved 
among all species. The simultaneous phosphorylation of sites Thr 37, Thr 46, Ser 65, and Thr 70 
are crucial for separation of 4E-BP1 from eIF4E. This simultaneous phosphorylation process 
occurs in a specific order as well. Two sites are initially phosphorylated on 4E-BP1, which 
primes the protein for subsequent phosphorylation on the Thr 70 site and lastly the Ser 65 site, 
which results in the release of 4E-BP1 from eIF4E [57, 58]. For this reason, we chose to analyze 
the phosphorylation status of 4E-BP1 at residue Ser 65 as it is the last site phosphorylated for 
complete dissociation from eIF4E. 
From the collected data, we observed that in B virus infected HFF and RMF cells, 4E-
BP1 hyperphosphorylation occurred at basal levels in uninfected and MCL-treated HFF and 
RMF, indicating that basal levels are necessary for everyday cell function. When HFF and RMF 
were infected with B virus (MOI 5), levels of hyperphosphorylated of p38 increased, indicating 
that eIF4E becomes available for phosphorylation. This was expected, as 4E-BP1 must be 
inactivated to release eIF4E so that it can be phosphorylated and translation can commence, 
which is critical for translation of viral mRNAs essential for the production of structural proteins 
of the virus. When p38 activity is ablated in HFF during infection, 4E-BP1 hyperphosphorylation 
is maintained, indicating that this occurs in a p38-independent manner.  In RMFs infected with B 
virus in the absence of p-p38, hyperphosphorylation levels were significantly reduced to levels 
observed in uninfected RMFs (FIG 7). These data suggest several scenarios. The reduction in 
hyperphosphorylation can indicate more non-phosphorylated 4E-BP1 bound to eIF4E. Because 
our data indicated that eIF4E phosphorylation was independent of p-p38 levels in B virus 
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infected RMF, this is unlikely. Alternatively, this finding could also be indicative of proteosomal 
degradation of 4E-BP1. After hyperphosphorylation, 4E-BP1 molecules are tagged for 
proteosomal degradation if the phosphate groups are not promptly removed by a phosphatase. 
Because of this, we designed experiments to determine if total levels of phosphorylated 4E-BP1 
were being decreased in the absence of p-p38 (FIG 8). The results of this experiment revealed 
that the total level of phosphorylated 4E-BP1 remained relatively similar in all of our treatment 
groups strongly suggesting that phosphorylated 4E-BP1 is not being degraded by the proteasome 
during B virus infection of either cell type. 
2.6 Viral titers increase in the absence of p38 in a host-dependent manner 
Because of our findings showing the p38-independent phosphorylation status of eIF4E 
and p38-dependent phosphorylation of 4E-BP1 during infection in the presence and absence of 
p38 in HFF and RMF, we quantified virus replication. We predicted that the cellular stress 
pathway MAPK p38 is activated by B virus infection to down-regulate virus replication in an 
effort to protect the host. To determine whether or not cell proteins critical for effective mRNA 
translation are affected by the MAPK p38 pathway during B virus infection, we inhibited this 
pathway to evaluate its role in productive viral replication. Our data from this experiment 
revealed that in HFF, viral titers do not change in the absence of p38, suggesting that in these 
primary human cells stress pathways fail to modulate virus replication. In RMFs, viral titers 
increased by almost one log in the absence of p-p38 compared with cells in which the MAPK 
p38 pathway was active (FIG 9). These data suggest for the first time that p38 plays a regulatory 
role in viral replication in the natural host, but fails to modulate B virus infection in the foreign 
host cells at the site of virus entry. This is the first insight into potential mechanisms that have 
been selected in the natural host after the opportunities of millennia of co-evolution. This 
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observation provides valuable insight into how zoonotic viruses gain a deadly advantage over 
humans where there have been no evolutionary opportunities for the virus and host to adapt to 
each other. 
2.7 Aim I Conclusions 
Because viruses require cellular machinery to replicate, we selected the MAPK p38 stress 
pathway to study its function during zoonotic viral invasion, using a cell-based model of species-
specific infection. In the absence of adequate animal models to study zoonotic infection and the 
costly in vivo studies in the natural host of B virus, we established a cell model system to 
investigate potential differences that may exist in the natural versus the human host cells targeted 
upon virus entry. The use of this cell model system allows the use of many essential controls and 
the isolation of specific innate defense pathways. The particular interest for this dissertation 
research was to enhance our understanding of cell translational machinery and thus we focused 
our studies on the translation factor eIF4E, which is crucial to cap-dependent translation, and 
additionally on 4E-BP1, one of the critical regulators of eIF4E in addition to p38 and ERK. In 
our findings, we showed that eIF4E phosphorylation during B virus infection of macaque and 
human cells occurred independently of stress pathways. Our data suggest that although B virus 
infection of human cells targeted at virus entry does not significantly impact eIF4E 
phosphorylation to enhance or decrease mRNA translation via the MAPK p38 pathway, macaque 
cells may effectively use this pathway to limit virus replication to levels that can be controlled by 
host defenses. Investigators have long appreciated that macaques quickly produce serum 
antibodies within 10-14 days post B virus infection, whereas humans produced only low and 
inconsistent levels of these antibodies. The reason for this remains unknown. We sought to 
explore whether innate cellular defenses may differ between macaque and human hosts, 
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particularly since the relationship between B virus and the macaque host have evolved over 
millennia, providing many opportunities for selection that allows co-existence of the virus and 
macaque host, whereas humans have not had this opportunity.   
Because 4E-BP1 hyperphosphorylation was identified as a critical mechanism which 
HSV1 and human hosts selected during their co-evolution, we asked whether this particular 
aspect of infection was conserved between B virus and its natural host, macaques. Using our 
developed comparative cell culture model system, we discovered that without effective MAPK 
p38 stress pathway activation, RMFs infected with B virus were observed to have a significant 
decrease of  in 4E-BP1 hyperphosphorylation levels comparable to the levels seen in uninfected 
cells while levels in HFF remained unaffected. This data suggested to us that in RMF there 
should be increased free 4E-BP1 available to bind and sequester eIF4E; however, 
phosphorylation of eIF4E was not significantly affected in RMF. These observations beg the 
question of what is preventing this free, hypophosphorylated 4E-BP1 from binding eIF4E and 
preventing translation. To ensure that the decrease in hyperphosphorylated 4E-BP1 was not due 
to proteosomal degradation, we compared the levels of total 4E-BP1 during infection in the 
presence or absence of p-p38 and discovered that levels of total 4E-BP1 were maintained 
independently of the MAPK p38 stress pathway activation. These observations suggested to us 
that a viral protein may dephosphorylate 4E-BP1 and or/block degradation. 
In the experiments designed to better understand the dynamic of the host:virus 
interactions, we observed that in B virus infected RMFs, 4E-BP1 hyperphosphorylation 
increased compared to uninfected cells. This suggested that eIF4E was free to be phosphorylated 
and participate in translation. When p38 phosphorylation is blocked, we expected that eIF4E 
phosphorylation would decrease because it is downstream of p-p38 but that was not what we 
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observed. Instead eIF4E phosphorylation did not significantly change whether the MAPK p38 
stress pathways were activated or not in our experiments. These data suggested to us that there is 
another protein responsible for eIF4E phosphorylation and this could potentially be a viral 
protein. 
The data presented here have shown for the first time that macaque-specific MAPK p38 
stress pathways affect host:virus interactions differently than human-specific MAPK p38 
pathways. To our knowledge, this is one of the first reported observations of species differences 
in host:virus interactions involving the MAPK p38 cellular stress pathway.  In primary RMF 
cells, which are representative of the cells at the site of primary infection in the natural host, the 
absence of a viable MAPK p38 response results in almost a log increase in virus titers; however, 
in HFF, which are representative of the cells at the site of primary infection in the human host, B 
virus replication is unfettered by the activation of the MAPK p38 stress pathway. This data 
suggests for the first time that p38 plays a key role in dampening virus replication in RMF but 
not in B virus infected primary HFF cells.  
Several independent investigators have provided evidence that certain specific viral 
proteins have the ability to control translation machinery or mimic the machinery. For example, 
HSV1 viral proteins have been shown to manipulate formation of the eIF4F complex [29], and 
hantavirus provides a protein that mimics the complex to enhance viral mRNA translation [30]. 
Therefore it is possible that like HSV1, a B virus protein can interfere with one or both of these 
processes involving eIF4E. Our experiments described in this dissertation demonstrated that p-
p38 does not regulate eIF4E phosphorylation in a host-dependent manner during B virus 
infection; however, the host-dependent regulation of 4E-BP1 during infection in the absence of 
p38 activity was demonstrated.  These findings potentially serve to illuminate how this zoonotic 
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virus regulates cellular pathways differentially between hosts. These data demonstrate how a 
zoonotic virus, in this case B virus, can regulate a cellular process in the natural host with which 
it has co-evolved, but not in the foreign human host and suggest how these interactions can 
contribute to the host-specific differences in the outcome of virus infection. Once it is known 
how a zoonotic virus interacts with its natural host cell and its human host cells, we will then 
have the possibility of designing intelligent antiviral therapeutics and vaccines. 
 
2.8 Figures 
 
 
Figure 1: Phosphorylated p38 through 24 hrs B virus infection in HFF and RMF 
 
Figure 1: Phosphorylated p38 through 24 hours post B virus infection in HFF and RMF. 
(Top) Western blot analysis of HFF and RMF treated with mock cell lysate (M) or infected with 
B virus at MOI 5 (B) at various times through 24 hours. (Bottom) Densitometric analysis of 
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phospho-p38 normalized to the amount of GAPDH in each sample. Figures are representative of 
three independent experiments in duplicate. 
 
 
 
 
 
 
Figure 2: Phosphorylated eIF4E through 24 hrs. B virus infection in HFF and RMF 
 
 
Figure 2: Phosphorylated eIF4E through 24 hours post B virus infection in HFF and 
RMF. (Top) Western blot analysis of HFF and RMF uninfected (U), treated with mock cell 
lysate (M) or infected with B virus at MOI 5 (B) at various times through 24 hours. (Bottom) 
Densitometric analysis of phospho-eIF4E normalized to the amount of GAPDH in each sample. 
Figures are representative of three independent experiments in duplicate. 
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Figure 3: Verification of p38 inhibition via SB203580 in HFF and RMF  
 
Figure 3: Verification of p38 inhibition via SB203580 in HFF and RMF. (Top) Western 
blot analysis of HFF and RMF uninfected (U), treated with mock cell lysate (M), infected with B 
virus at MOI 5 (B), or infected with BV and treated with SB203580 (p38i) for 24 hours. 
(Bottom) Densitometric analysis of phospho-p38 normalized to the amount of beta tubulin in 
each sample. Figures are representative of three independent experiments in duplicate. 
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Figure 4: eIF4E phosphorylation occurs independently of p38 in HFF and RMF 
 
Figure 4: eIF4E phosphorylation occurs independently of p38 in HFF and RMF. A) 
Western blot analysis of HFF and RMF, uninfected (U), treated with mock cell lysate (M), 
infected with B virus at MOI 5 (B), or infected with BV and treated with SB203580 (p38i) for 24 
hours. B) Densitometric analysis of phospho- eIF4E normalized to the amount of beta tubulin in 
each sample. Figures are representative of three independent experiments in duplicate.  
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Figure 5: ERK phosphorylation is downregulated late in B virus infection.  
 
Figure 5: ERK phosphorylation is downregulated late in B virus infection. A) Western 
blot analysis of HFF and RMF, treated with mock cell lysate (M), or infected with B virus at 
MOI 5 (B), at various time points through 24 hours. B) Densitometric analysis of phospho- 
ERK1/2 normalized to the amount of beta tubulin in each sample. Figures are representative of 
three independent experiments in duplicate.  
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Figure 6: ERK phosphorylation is unaffected by p38 during B virus infection 
 
Figure 6: ERK phosphorylation is unaffected by p38 during B virus infection. A) Western 
blot analysis of HFF and RMF, uninfected (U), treated with mock cell lysate (M), infected with 
B virus at MOI 5 (B), or infected with BV and treated with SB203580 (p38i) for 24 hours. B) 
Densitometric analysis of phospho- ERK2 normalized to the amount of beta tubulin in each 
sample. Figures are representative of three independent experiments in duplicate.  
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Figure 7: 4E-BP1 hyperphosphorylation requires p38 in the natural host  
 
Figure 7. 4E-BP1 hyperphosphorylation requires p38 in the natural host during B virus 
infection. A) Western blot analysis of HFF and RMF, uninfected (U), treated with mock cell 
lysate (M), infected with B virus at MOI 5 (B), or infected with BV and treated with SB203580 
(p38i) for 24 hours. B) Densitometric analysis of phospho-4E-BP1 (S65) normalized to the 
amount of beta tubulin in each sample. Figures are representative of three independent 
experiments in duplicate.  
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Figure 8: Total 4E-BP1 is not regulated by p38 during B virus infection 
 
Figure 8. Total levels of 4E-BP1 are not regulated by p38 during B virus infection in 
RMF. (Top) Western blot analysis of HFF and RMF, uninfected (U), treated with mock cell 
lysate (M), infected with B virus at MOI 5 (B), or infected with BV and treated with SB203580 
(p38i) for 24 hours. (Bottom) Densitometric analysis of phospho-4E-BP1 (S65) normalized to 
the amount of beta tubulin in each sample. Figures are representative of three independent 
experiments in duplicate.  
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Figure 9: Active p38 regulates B virus titers in a host-dependent manner.  
 
Figure 9: Active p38 regulates B virus titers in a host-dependent manner. Cells were 
pretreated for 1 hour prior to infection with SB203580. After pretreatment cells were infected 
with either BV only or BV in the presence of SB203580 (p38i) for 24 hours. Samples were then 
scraped and collected. Serial dilutions were made of these samples and used to infect VERO 
cells in duplicate. After 48 hours virus was removed, cells were fixed with methanol and stained 
with crystal violet. Plaques were counted and PFU/ml was determined. Figures are representative 
of two independent experiments in duplicate. 
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3 AIM II: TEST THE HYPOTHESIS THAT INTERACTIONS BETWEEN B VIRUS 
PROTEIN ICP6 AND US3 WITH CELLULAR TRANSLATION PROTEINS ARE 
REGULATED BY THE MAPK P38 STRESS PATHWAY DURING B VIRUS 
INFECTION 
In the previous aim we explored the virus:host species interactions between p38 and 
cellular translation during B virus infection in macaque and human cells representative of those 
encountered at the time of virus entry. Our data demonstrated that although p38 plays a role in 
virus replication in the natural host, this role does not appear to be related to regulation of the 
translation initiation factor eIF4E phosphorylation. This latter regulation appears to rely on other 
processes that occur during infection. Interestingly, we discovered that the negative regulator of 
eIF4E, 4E-BP1, is in fact regulated by p38 in macaque fibroblasts under our experimental 
conditions. As a negative regulator 4E-BP1 binds to eIF4E and prevents its association with 
eIF4G, thus blocking its phosphorylation by cellular protein MNK. This prevents eIF4E 
activation and subsequently, mRNA translation. Cellular 4E-BP1 becomes inactive when it is 
hyperphosphorylated by mTOR, leaving eIF4E to be phosphorylated and activated by MNK and 
allowing translation to commence. During B virus infection of macaque fibroblasts, we see a 
significant increase of 4E-BP1 hyperphosphorylation, presumably to allow for translation of viral 
mRNA to occur unhindered. When p38 activation is inhibited during B virus infection, this 
increase in hyperphosphorylation fails to occur indicating that p38 plays a critical role in causing 
the hyperphosphorylation of 4E-BP1 during B virus infection in macaque fibroblasts. 
To determine what causes the decrease in hyperphosphorylation of 4E-BP1 in RMF 
during B virus infection in the absence of the MAPK p38 stress pathway, we considered three 
possible scenarios: 1) The positive regulator of 4E-BP1, PPM1G, is being upregulated in the 
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absence of p38; 2) The negative regulator of 4E-BP1, mTOR is being downregulated in the 
absence of p38; 3) Viral proteins capable of interacting with cellular translational machinery are 
overriding the cellular machinery resulting in increased viral replication to facilitate infection. 
These scenarios will each be investigated in this second Specific Aim of the dissertation. 
Protein Phosphatase 1G (PPM1G) is a member of the PP2C phosphatase family and 
removes phosphate groups from serine and threonine residues on proteins. This can be an 
activation or inactivation modification. Certain members of the PP2C family are negative 
regulators of cellular stress response pathways. PPM1G dephosphorylates pre-mRNA splicing 
factors and allowing the formation of the spliceosome. In vivo studies also suggest that PPM1G 
may play a role in regulating cell cycle progression. Furthermore, PPM1G has been shown to 
dephosphorylate multiple phosphorylation sites of 4E-BP1, thereby regulating cap-dependent 
cellular translation [59].  
Mammalian target of rapamycin (mTOR) was first discovered in 1994 [60]. The 
mammalian genome produces one TOR protein that has a high molecular weight and has several 
structural domains that are conserved [58]. mTOR can be autophosphorylated by its own 
serine/threonine kinase activity and regulates protein synthesis via regulation of 4E-BP1 and S6 
kinase (S6K1) phosphorylation [61, 62]. mTOR is regulated by nutrients and growth factors and 
controls many processes including, but not limited to cellular translational control, cell growth, 
and proliferation [58]. The translational repressor 4E-BP1 is a well known target of mTOR 
phosphorylation. By phosphorylating 4E-BP1, mTOR inactivates it causing it to release eIF4E. 
Once released, eIF4E can be phosphorylated and assemble into the initiation complex, which is a 
crucial step in cap-dependent translation. Other targets consist of proteins that are important for 
translation, in particular those that are responsible for recruiting ribosomes to mRNA.  
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mTOR is also responsible for phosphorylation of eukaryotic initiation factor 4G 1 
(eIF4GI). eIF4G contains two groups of phosphorylation sites-one near the N-terminus [63] and 
the other near the C-terminus, though it is unclear what stimulates the phosphorylation at the N-
terminus. The phosphorylation sites near the C-terminus is sensitive to mTOR inhibitors [64]. 
Because mTOR regulates the phosphorylation of three important proteins in the cellular 
translational process, we analyzed whether its activity in response to B virus infection may be 
related to our observations regarding the regulation of eIF4E.  
While mTOR and PPM1G are both cellular proteins capable of modifying other cellular 
proteins that regulate translation, there are also viral proteins of herpesviruses that are known to 
regulate use of cellular translational machinery. 
Three classes of herpes simplex virus genes are known to be expressed during the virus 
replication cycle and these are divided into each class by the kinetics and regulation of their 
expression [65]. The first class to be expressed, or the alpha class, is the group of immediate 
early (IE) genes. Their expression is dependent on the viral protein alpha-transinducing factor 
(TIF) or viral protein 16 (VP16) that interacts with the cellular transcription factor Oct-1 as well 
as other cellular proteins to drive transcription [66]. The next class to be expressed is the beta 
class or the early (E) genes. These genes require the presence of some of the IE proteins for 
expression. The third class, or the gamma class, are the Late (L) genes that are expressed after 
the viral DNA has been replicated. This last group can be further divided into groups that either 
require DNA synthesis for expression or that do not. Some of these late genes are actually 
expressed throughout the viral replication cycle while others are restricted to the final stages of 
replication. These classes of viral genes have been described in great detail over the course of 
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many studies in many different laboratories and have been reviewed in depth by Roizman and 
colleagues [67]. 
 HSV1, perhaps the most studied member of the alphaherpesvirus simplex viruses of 
which B virus is also a member, produces two viral proteins that have been shown to play 
intricate roles in the regulation of translation via manipulation of eIF4E and 4E-BP1. Infected 
cell protein (ICP) 6, encoded by the gene UL39, of HSV1 has been shown to associate with 
eIF4G, a scaffolding protein responsible for bringing eIF4E and MNK1 in close proximity. This 
promotes eIF4F complex formation [68].  
The gene UL39 encodes the large subunit of the ICP6, which is a ribonucleotide 
reductase. The function of this protein is to reduce ribonucleotides to deoxyribonucleotides that 
can then be incorporated into growing DNA strands. Because of its function, ICP6 is very 
important for viral DNA synthesis, neurovirulence and reactivation as demonstrated in several 
animal models and countless studies [66, 69, 70]. 
In 2006 Walsh and colleagues it was discovered that HSV1 ICP6 was discovered to be an 
eIF4F assembly chaperone that induced and enhanced complex formation necessary to drive 
translational processes [68]. Because of the role of ICP6 in eIF4F complex formation in HSV1 
infection, we designed experiments to investigate whether or not the role B virus ICP6 within its 
natural host and how this role may be manipulated in the absence of p38.  
A second viral protein of particular interest to us with respect to virus:host interactions at 
the translational level is the protein encoded by the US3 gene. This gene encodes a protein 
kinase that forms a homodimer in both HSV1 and HSV2, though their molecular weights are 
different. US3 does not require any effectors for activity and transfers phosphate groups only 
from ATP, rather than GTP to serine and threonine residues [71]. US3 also has 
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autophosphorylation capabilities. Previous work suggests that the protein kinase activity of US3 
is encoded by the open reading frame [72, 73]. During HSV1 infection, US3 is responsible for 
phosphorylating the viral protein encoded by UL34, which is an abundant nonglycosylated virion 
protein that is likely a type II membrane protein. Reynolds and colleagues revealed that this 
protein is localized within the nuclear membrane and is necessary for packing progeny virus into 
envelopes [67, 74] 
The US3 of HSV1 has been shown to act as an Akt-like protein that activates mTOR, 
which in turn affects the activation or deactivation of 4E-BP1. The US3 also phosphorylates the 
tuberous sclerosis complex 2 (TSC2) on the same residues that are phosphorylated by Akt. This 
phosphorylation of TSC2 inactivates the protein, which prevents it from inactivating mTOR, thus 
making mTOR constitutively active [75]. HSV1 US3 also inactivates Akt by dampening activity 
of viral proteins VP11 and VP12 [76]. Because US3 plays an important role in regulating 
translational processes during HSV1 infection, we targeted B virus US3 within the natural host 
to investigate its potential role in regulation of cellular translational machinery. The work 
proposed in this aim was designed to determine if ICP6 and/or US3 present in B virus had 
conserved functions with counterparts in HSV1 and whether or not these functions were 
dependent upon which host was infected by B virus. Arguably, we could assume that at least 
within the macaque host cells the functions of these homologues are conserved. To begin, we 
transfected CHO cells to express each of these viral proteins. This was done to verify that our 
plasmids were producing whole and functional protein product and that p38 inhibition did not 
interfere with the transfection, nor did either of these transfected proteins compromise the 
MAPK p38 stress pathways. From there we moved into a more cell relevant model using rhesus 
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macaque fibroblasts (RMF) as representatives of cells infected during primary infection events 
within the natural host.  
3.1 PPM1G activity is not induced by B virus activation of MAPK p38 
As with any biological process, there are checks and balances that regulate protein 
expression and activation. In the case of 4E-BP1 mTOR functions as a negative regulator 
wherein it adds phosphate groups to the protein to inactivate it thus 4E-BP1 also requires a 
positive regulator. The positive regulator of 4E-BP1 is the protein phosphatase PPM1G [59].  
As previously discussed, PPM1G belongs to a group of phosphatases that remove 
phosphates from serine and threonine residues. This group can be divided into two families: the 
phosphoprotein phosphatases (PPP) and the metal-dependent protein phosphatases (PPM). 
PPM1G belongs to the PPM family and has been shown to promote the association of 4E-BP1 
with the eIF4F cap complex through the dephosphorylation of specific residues of 4E-BP1 [59].  
Because of the role that PPM1G plays in 4E-BP1 regulation, it was necessary to identify 
if p38 inhibition had any affect on its expression and if so, to what extent and whether or not it 
was in a host-dependent manner. To investigate this question, we performed our inhibition assay 
followed by western blot and densitometric analyses (FIG 10). 
Our results indicate that PPM1G was expressed at basal levels in the untreated and MCL 
treated RMF. This basal level of expression indicates that PPM1G plays a role in the normal 
everyday function of the cell to regulate translation of mRNAs. When B virus (MOI 5) was used 
to infect RMF, no substantial changes were observed in PPM1G expression suggesting that 
PPM1G was not activated in response to stress pathway activation. When p38 activity is ablated 
during exposure to B virus, again we did not observe a significant modification of PPM1G 
expression. The stability of PPM1G expression in the presence of virus, as well as in the absence 
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of p38 activity, suggests that its activity occurs independently of the cellular stress responses 
associated with B virus activation of the MAPK p38 stress response. From these data, we 
concluded that the observed p38-dependent decrease in phosphorylation of 4E-BP1 was not 
attributable to the upregulation of PPM1G to remove the inactivating phosphate groups. Because 
PPM1G activity was not altered by the inhibition of p38, we decided to further investigate the 
activity of mTOR during B virus infection as it also plays a role in the regulation of 4E-BP1 and 
has been shown to be susceptible to being regulated by viral proteins. 
 
3.2 mTOR activity is unaffected by B virus activation of MAPK p38 
As the negative regulator of 4E-BP1, mTOR adds phosphate groups to the different 
phosphorylation sites on 4E-BP1. This hyperphosphorylation via mTOR prevents 4E-BP1 from 
attaching to eIF4E and acting as an inhibitory regulator to cellular translation. Not only does 
mTOR phosphorylate 4E-BP1, but it has also been shown to phosphorylate other translational 
proteins such as eIF4G and eIF4B, both of which play crucial roles in the initiation phase of 
translation [58]. Because mTOR mediates phosphorylation of several factors involved in the 
initiation phase of translation, we next considered how B virus activation of MAPK p38 stress 
pathways affect mTOR. To experimentally evaluate our consideration, we collected samples 
from our inhibition assays and performed western blots and densitometric analyses to measure 
relative levels of mTOR phosphorylation attributable to the activation of MAPK p38 stress 
response (FIG 11).  
Our results confirmed that in untreated and MCL treated cells, mTOR was activated at 
basal levels. Because this protein regulates several processes within the cell, this was predictable. 
Our data revealed that B virus did not increase or decrease mTOR phosphorylation and 
45 
activation beyond apparent basal levels found in unmanipulated cells. These findings strongly 
suggested that B virus does not regulate the mTOR pathway, but the question remained that 
perhaps B virus exploits the pathway for efficient viral replication and spread thus the pathways 
remains unperturbed by the infection. When p38 phosphorylation was inhibited, we observed no 
significant changes in the levels of phosphorylated mTOR. It is important to note that once 
phosphorylated, mTOR can be activated by stimulants to do a variety of tasks including 
phosphorylation of 4E-BP1. Some of these stimulants require basal levels of p38 
phosphorylation to stimulate mTOR to phosphorylate 4E-BP1 [77]. This could explain our 
observed decrease in levels of phosphorylated 4E-BP1 in RMF cells treated with the inhibitor of 
MAPK p38 phosphorylation. Together, our data indicate that mTOR can generally phosphorylate 
n4E-BP1 independently of the MAPK p38 stress pathway. 
3.3 ICP6 is unnecessary to enhance eIF4F activity in the presence of p38. 
In HSV1, Walsh and colleagues determined that ICP6, which is a ribonucleotide 
reductase, interacts with eIF4G to enhance viral protein production during infection. In HSV1 
infected cells ICP6 acts as an eIF4F-assembly chaperone and is the first example of a protein that 
promotes eIF4F complex formation during viral infection [68]. From our previous work 
sequencing the complete B virus genome, we identified ORFs present in the B virus genome. Of 
those, UL39 and UL40 were predicted to encode the large and small subunit of the 
ribonucleotide reductase, respectively. B virus ICP6 shares approximately 71% identity with 
HSV1 ICP6 and approximately 73% with HSV2 ICP6, though similarity is slightly higher at 
77% and 78%, respectively [4]. Because of the high rate of similarity, we hypothesized that the 
ribonucleotide reductase in B virus had similar functions to that of HSV1. Using this information 
we next planned experiments to determine if ICP6 is capable of regulating eIF4F complex in the 
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presence or absence of p38 in RMF [78]. To investigate the role of B virus ICP6, we inserted the 
UL39 gene into a pcDNA vector and transiently transfected Chinese hamster ovarian (CHO) 
cells in the presence or absence of p38. We then collected whole cell lysate and conducted 
Western blot and densitometric analyses to observe phosphorylation and activation of eukaryotic 
initiation factors that are members of the eIF4F complex. To begin, we first needed to verify the 
successful transfection of UL39 into CHO cells (FIG 12). We verified successful protein 
production by detection of the V5 epitope present within the vector. 
Because we were uncertain of how efficient the transfection would be, we transfected 
cells with either two or four micrograms of plasmid DNA and compared the levels of V5 epitope 
expression. In cells transfected with two micrograms, we observed thick dark bands 
corresponding to B virus ICP6 with the expected molecular weight of approximately 115.7 kD. 
There is also an equally dark band directly below our ICP6 band as well as a few much lighter 
bands. These bands are likely generated from degradation of the translated protein as well as 
some non-specific binding of the anti-V5 antibody in the case of the lighter bands. Alternatively, 
phosphorylation at multiple sites may have resulted in products of varied molecular weight of the 
protein. The same bands were seen in western blots prepared from cells transfected with four 
micrograms; however, expression of the V5 epitope was verified in both groups, validating that 
we were able to successfully transfect CHO cells with our UL39 plasmid. In the untransfected 
cells, designated in the figure as “Un”, we see no detectable V5 epitope. These cells were used as 
a negative control.  
With our transfection assay yielding predicted outcomes, our next step was to inhibit p38 
activity while simultaneously transfecting these CHO cells to validate that cells remained healthy 
(FIG 13). Because we had efficient transfection yields with transfecting only 2 μg of DNA, we 
47 
standardized transfections using 2 μg from this experiment forward.  When CHO cells are 
transfected with 2 μg of plasmid DNA, we observed a large dark band appearing at 
approximately 115 kD as was previously noted. In conjunction with V5, we also see expression 
of phosphorylated p38. In untransfected cells, we observed neither the expression of V5 nor p38. 
Expression of ICP6 was sufficient to activate p38. In CHO cells treated with the p38 inhibitor, 
we readily detected the V5 epitope of the fusion peptide validating B virus ICP6 protein was 
produced. We also saw significant reduction in p38 phosphorylation. In the untransfected cells 
treated with p38 inhibitor, we observed neither V5-fusion protein expression nor p38 
phosphorylation. These data reveal that ICP6 alone is capable of inducing p38 phosphorylation 
in CHO cells and that transfection and simultaneous inhibition of p38 phosphorylation are 
achievable in this cell line. 
To determine whether or not ICP6 was capable of affecting the assembly of the 
translation initiation comples in the presence or absence of the MAPK p38 stress pathway 
activation, we transfected with our plasmid bearing ICP6 into cells with functional MAPK p38 
stress pathways (FIG 14). Results of this experiment revealed expression of eIF4G 
phosphorylation. Investigators have reported that phosphorylation of eIF4G is not necessarily 
indicative of activation of function, but this modification may cause a conformational change in 
the protein that affects its activity [79]. In cells that were not transfected with ICP6, we see very 
similar levels of eIF4G phosphorylation, suggesting that B virus ICP6 does not enhance the 
phosphorylation of eIF4G. When the stress pathway was inhibited as described, the levels of 
eIF4G phosphorylation remained unchanged validating that p38 activity is not necessary for 
eIF4G phosphorylation. When the phosphorylation status of eIF4E was explored, very 
interesting results were observed. In untransfected cells, we observed basal levels of eIF4E 
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phosphorylation indicating a normal level of activation. When B virus ICP6 was transfected into 
these cells, we observed a marked decrease in eIF4E phosphorylation. This was in direct contrast 
to what we expected to see based on the fact that HSV1 ICP6 was reported to enhance the 
phosphorylation of eIF4E during infection. Inhibition of the MAPK p38 stress pathway revealed 
that levels of basal activity observed in untransfected cells decreased when compared to the 
untransfected cells in the presence of p38. The levels of eIF4E phosphorylation in cells 
transfected with B virus ICP6 were independent of the functional stress pathways. Together, 
these data suggested that B virus ICP6 appeared to have the opposite role of the HSV1 ICP6 
homolog, causing a decrease in phosphorylation of eIF4E, which would be predicted to cause a 
decrease in the rate at which translation occurs within the cell. Because these results were 
obtained in CHO cells, which are not representative cell populations of primary infection sites in 
the natural host, the transfection assays were subsequently performed in the RMF cell line in 
order to confirm that B virus ICP6 behaves the same way in the RMF as it does in the CHO cells 
or to show that ICP6 acts differently depending on the cell type.  
3.4 B virus US3 requires the presence of phosphorylated p38 to stimulate mTOR and, in 
turn, 4E-BP1 inactivation. 
Once we examined the role of ICP6 in the presence and absence of p38 activity, we 
focused on discerning the effects of p38 on B virus US3. Investigators have reported that HSV1 
US3 behaves like the cellular protein kinase Akt and phosphorylates several of its substrates 
including mTOR, yet shares little or no sequence homology with Akt. Data suggests that HSV1 
US3 activates mTOR by phosphorylating and inactivating TSC2, which is an inhibitory molecule 
to mTOR activitation. With TSC2 inactivated, mTOR can now be constitutively active and can 
phosphorylate its downstream effectors 4E-BP1 and S6K to enhance translational activity. B 
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virus US shares approximately 58% identity with HSV1 ICP6 and approximately 57% with 
HSV2 ICP6, though similarity is slightly higher at 70% and 65%, respectively. Even though the 
similarities between BV US3 and HSV1 and 2 US3 are not very high, it was still important to 
determine what effect, if any BV US3 has on this particular pathway as this protein in B virus 
has not been previously studied. To analyze the effect of B virus US3 in the presence and 
absence of p38, we expressed B virus US3 in CHO cells and simultaneously inhibited p38 
phosphorylation. We analyzed the whole cell lysate samples collected using western blot and 
subsequent densitometric analyses. As before, we began with a CHO cell model to optimize our 
transfection and inhibition assay and from there, moved into a more relevant cell model using the 
RMFs to analyze the effects of US3 in the presence and absence of p38 activity. 
To begin, we first analyzed the efficiency of transfection of B virus US3 into CHO cells 
(FIG 15). Again we transfected with two or four micrograms of plasmid containing the B virus 
US3 insert to determine which concentration of DNA was optimal and analyzed expression of 
the V5 epitope of the expressed fusion protein. We observed two dense bands in both the two 
and four microgram transfected cells correlating with our expected molecular weight of 
approximately 55.5 kD. The doublet bands were to be expected as this protein forms 
homodimers. Other lighter and smaller bands were also observed at lower molecular weights. 
These could be the degradation from the expressed protein or non-specific anti-V5 antibody 
binding. Our data showed that US3 was successfully transfected into CHO cells. Our next step 
was to analyze transfection of US3 in the presence and absence of p38 in CHO cells (FIG 16). 
Our results showed that in cells transfected with B virus US3, p38 phosphorylation was 
apparent indicating that the presence US3 resulted in phosphorylation and activation of p38. In 
our vector-transfected cells, we see neither the V5-tagged fusion protein nor p38 phosphorylation 
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and the same is true when the untransfected cells were analyzed. These observations suggest that 
in the absence of B virus US3, p38 is not phosphorylated which suggests the cell remains 
unstressed, or during stress this viral protein may block the activation of the pathway. When p38 
activity is inhibited, US3 expression is observed, but phosphorylation of p38 is significantly 
reduced. This indicated to us that the inhibition was successful and did not interfere with 
expression of US3 from the vector. In the absence of p38, the vector-transfected and 
untransfected cells showed neither V5-tagged fusion protein expression nor p38 phosphorylation. 
Once we optimized our transfection and simultaneous inhibition assay for the use of plasmids 
containing US3 in CHO cells, we validated the effects US3 had on mTOR and its downstream 
effector 4E-BP1 in the presence and absence of p38 activity.  
The first protein we analyzed was mTOR phosphorylation (FIG 17). In US3 transfected 
cells we observed phosphorylated mTOR relatively increased when compared to the vector-
transfected and the untransfected cells. This observation is what we predicted as we know that 
HSV1 US3 is capable of phosphorylating mTOR and inducing its activity. When p38 activity 
was ablated, we did not observe upregulation of mTOR phosphorylation noted to occur in the 
presence of p38. Thus B virus US3 appears to increase levels of phosphorylated mTOR, but this 
requires activated MAPK p38. The levels of mTOR phosphorylation remained the same in 
vector-transfected and untransfected cells remained the same in the absence of p38 activity. 
Because we know that HSV1 US3 acts like cellular kinase Akt and is capable of 
downregulating its activity, we examined at the effect of US3 on Akt phosphorylation expression 
levels and whether or not this was modulated by the presence of p38 (FIG 18). From these 
experiments we observed that in the presence of B virus US3, Akt phosphorylation occurs 
independently of MAPK p38 stress pathway activation. Phosphorylated Akt levels were apparent 
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in western blots of US3 transfected cell lysate, but observed levels were comparable to levels 
seen in empty vector-transfected and untransfected cells. When p38 activity was inhibited, the 
levels of phosphorylated Akt remained unchanged. This data suggested that B virus US3 did not 
interfere with phosphorylated Akt levels, despite taking over some of the functions of Akt. These 
observations provide strong support that B virus US3 does not share at least one function of 
HSV1 US3, the latter which appears to have diverged with respect to this function. This 
functional difference could be associated with sequence differences between HSV1 ICP6 and B 
virus ICP6, or that in CHO cells US3 behaves differently than it would in its natural host. 
Lastly, we looked at the effect of US3 on hyperphosphorylation of 4E-BP1 in the 
presence and absence of phosphorylated p38 (FIG 19).  In US3 transfected cells, we see 
hyperphosphorylation of 4E-BP1 levels that are comparable to the vector-transfected and 
untransfected cells indicating that B virus US3 does not enhance or reduce 4E-BP1 
phosphorylation in the presence of functional MAPK p38 stress responses. In the absence of p38, 
in US3 transfected cells 4E-BP1 phosphorylation is significantly reduced when compared to the 
empty vector-transfected and untreated cells without p38 activity. These observations provide 
evidence that the MAPK p38 stress pathway is essential for US3 function for the maintenance of 
4E-BP1 hyperphosphorylation, most likely through the activation of mTOR. These findings 
agree with our initial findings of decreased levels of hyperphosphorylated of 4E-BP1 during B 
virus infection in the absence of p38 within cells of the natural host. As was stated earlier, 
because these results were obtained in CHO cells, the transfection assays were then performed 
using the primary RMF cell line in order to confirm that B virus US3 affects the RMF cells as it 
does in the CHO cells or to show that US3 has different effects depending on the cell species in 
which it is expressed. 
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3.5 Transfection of primary RMF cells with BV ICP6 and US3 
In previous experiments we have shown the effects of the presence of BV ICP6 and US3 
in Chinese hamster ovarian (CHO) cells; however, these results may differ when these virus 
proteins are expressed in cells from the natural host of B virus infection. For this reason, we 
attempted to transfect RMF with either ICP6 or US3 in the presence or absence of p38 activity to 
determine whether or not either or both viral proteins affected stress pathway function or 
required intact stress pathways for their individual functions. Primary cell transfection can be 
more challenging than transfecting immortalized cell lines like CHO cells. The reasons for this 
are unclear though differences in rates of transfection and tolerances of cytotoxic transfection 
reagents may contribute. Typically primary cells used in transfection assays are embryonic or 
stem cells. Our RMF cell line is isolated from macaques of different ages, most being adult 
animals. Successful isolation and growth of fibroblasts from adult macaques is challenging and 
because the cells are much older than the embryonic or stem cells typically used for transfection. 
To begin, we performed the same transfection assay used in the CHO cell line in the RMF cell 
line as described in the section Materials and Methods. This experiment failed to yield 
transfected cells and it was determined that rate of transfection was the probable cause. To 
optimize the transfection of RMF alone, we transfected cells as previously stated but without use 
of the MAPK p38 inhibitor SB203580 and instead of a 24-hour transfection period, we allowed 
the transfections to proceed for 48 hours and 72 hours for each protein. We found that B virus 
ICP6 requires 48 hours for transfection and expression of the protein in RMF (FIG 20) and that 
US3 requires 72 hours for transfection and expression of the protein in RMF (FIG 21). We also 
observed that unlike ICP6 and US3 expression in CHO cells, there were not multiple bands 
appearing in each sample set and no doublets, thus processing of these viral proteins in macaque 
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cells was likely different than that observed in transfected CHO cells. There is only one non-
specific band that appeared at approximately 37 kDa, which was also observed in untransfected 
cells indicating that the anti-V5 antibody cross-reacted with a cellular protein (data not shown).  
These results were encouraging considering the already difficult task of transfecting primary 
cells.  
Thereafter we first analyzed the effects of expressed ICP6 and US3 in RMF cells on the 
cellular proteins that may be activated or repressed by these viral proteins. Based on our 
optimization of ICP6 and US3 transfection, we transfected RMF cells with 2 μg of either UL39 
(ICP6) pcDNA or US3 pcDNA for 48 hours and 72 hours, respectively (FIG 22). We collected 
the whole cell lysate and analyzed an aliquot of this to determine relative levels of 
phosphorylated eIF4F complex members as well as phosphorylated mTOR. Phosphorylation of 
eIF4G, the scaffolding protein, was markedly decreased in transfected RMF, which is different 
from what is seen in UL39 transfected CHO cells; however, expression of phosphorylated eIF4G 
was also low in empty vector transfected RMF indicating that the transfection process itself was 
likely responsible for the decrease in eIF4G activation, perhaps due to the stress of transfection 
and not necessarily the presence of ICP6 (FIG 23). Despite the fact that eIF4G requires 
phosphorylation to be active, its activation does not correlate to the activation of eIF4E therefore, 
the transfection of UL39 may influence eIF4G phosphorylation independently of eIF4G 
activation. In UL39 transfected RMF, we observed a marked decrease also in eIF4E 
phosphorylation, which contradicts the observation of ICP6 activation of eIF4E in HSV1 
infected cells, but is similar to the results seen in UL39 transfected CHO cells [68] (FIG 24). 
Together, these results confirmed our observation in transfected CHO cells and thus suggested 
that the effects of ICP6 observed in CHO cells is indicative of its true nature in its natural host.  
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Phosphorylation of mTOR, the inactivator of 4E-BP1, appeared greatly decreased in US3 
transfected RMF (FIG 25). It is interesting to note that the RMF transfected with empty vector 
expressed even less phosphorylated mTOR, again indicating that the decrease in mTOR 
activation may be due to stress caused by the transfection process. These results are again 
opposite of those observed in transfected CHO cells expressing mTOR; however, this difference 
in mTOR activation may be due to stress as evidenced by the decreased in mTOR activation in 
cells only transfected with empty vector pcDNA as seen in the previous experiment described. 
We next designed experiments so that we could determine how expression of B virus 
ICP6 or US3 affected p38 activity and expression of cellular proteins. This task proved to be 
challenging due to what we attributed to the putative toxicity of the transfection reagents as well 
as the MAPK p38 inhibitor. The Lipofectamine™ reagents used in the transfection were toxic to 
the cells, but have been optimized by the company to minimize damage to the cells and 
maximize transfection; however, this optimization was done in established cell lines that are 
susceptible to transfection, not in primary cell lines. In RMF transfected with UL39 or US3 there 
were cytotoxic effects. Some cells had detached from the plate and were floating in the medium. 
Those that remained adhered to the plates were producing stress granules and significant cell 
rounding was observed. RMF transfected in the presence of SB203580 also had detached cells in 
the medium. To quantify the cytotoxicity of the transfection reagents and SB203580, we 
performed a Trypan blue exclusion assay to determine the ratio of dead cells to live ones. In 
RMF transfected with UL39, approximately 75% of cells are dead while 25% remain alive. In 
RMF transfected with empty vector, approximately 68% of cells are dead. In untransfected cells, 
we see that approximately 80% of cells are alive, indicating that the transfection reagents are 
causing significant cell death. When SB203580 is added to the transfection assay, the results are 
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similar, with slightly more cell death at approximately 80% of the total population (FIG 26). In 
RMF transfected with US3, we see approximately 65% of the total cell population is dead with a 
remaining 35% of cells still alive. In RMF transfected with empty vector, we see approximatel 
55% cell death and in untransfected cells, the majority of cells are alive at approximately 95% of 
the total cell population. In cells transfected with US3 in the presence of SB203580, we see 
approximately 72% of the total cell population is dead with 28% remaining alive. The empty 
vector transfected cells yield similar numbers while 90% of the total cell population of 
untransfected cells remains alive (FIG 27). Together, these data indicate that the Lipofectamine 
transfection reagents are causing significant cell death in RMF and although transfection is 
somewhat successful as indicated previously, the amount of stress induced within the cells masks 
any effect produced by the presence of the viral proteins in RMF. To further demonstrate the 
cytotoxicity of the transfection reagents to RMF, pictures of the cells under the various 
conditions were taken microscopically. In the control group, which is RMF in DMEM containing 
10% FBS, we see the typical morphology associated with this cell type. The cells are elongated 
at the ends and become thicker toward the center where the nucleus is housed. In the 
untransfected group, which is RMF in Opti-MEM as suggested by Lipofectamine transfection 
protocol, cell structure looks slightly different with cells appearing rounder in shape as opposed 
to elongated, but still no evidence of stress or dead cells as there are no cells floating in the 
medium. In the vector group, which is RMF transfected with empty vectors, we start to see signs 
of cytotoxicity such as cell rounding and cells floating. The results are the same with the addition 
of SB203580 (FIG 28).  RMF transfected with either UL39 or US3 show tremendous cytotoxic 
effects with symptoms such as detachment from the surface of the plate, cell rounding, and the 
production of stress granules, regardless of whether or not SB203580 is present (FIG 29). To 
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reduce the cytotoxicity, we reduced the amount of Lipofectamine reagents used to half of the 
recommended amounts. With reduced amounts of the transfection reagents the cells appeared 
healthier and there were less cells floating in the medium, but when the transfection was verified 
there was neither ICP6 nor US3 expressed (not shown). It was determined that simultaneous 
transfection and inhibition of p38 via SB203580 was not possible due to the fact that RMF are 
primary cells that are much older than primary cells usually used in transfection assays and that 
the sensitivity of the RMFs to the transfection reagents left the majority of cells dead. 
Alternatives to the use of SB203580 as an inhibition method will be discussed in the conclusions 
section of this aim. 
3.6 Aim II Conclusions 
The experimental questions that were explored in this second aim demonstrated four 
main points. First, that pcDNA vectors containing genes for B virus proteins ICP6 and US3 can 
be transfected into CHO cells to produce in tact, and functional proteins. Although CHO cells do 
not represent primary infection in the natural host or even a foreign host that is often exposed to 
B virus, this was a step forward in B virus research to begin determining the function of these 
important viral proteins during the course of infection and whether or not they have differing 
effects based on the host they occupy. Second, we showed that in CHO cells, B virus ICP6 does 
not enhance activation of the eIF4F complex. These results are in direct contrast to our expected 
findings as the ICP6 protein belonging to HSV1 is capable of enhancing activation of this 
complex. There are two obvious possibilities as to why these results differ from what was 
expected. The first is that CHO cells are not the natural host of this virus. In HSV1 studies, 
human cells were used therefore they were studying the effects of this protein within its natural 
host. The fact that ICP6 behaved differently from expected in CHO cells could be just a product 
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of the cell type that was transfected. The second possibility is that B virus ICP6 function really 
does differ from that of HSV1 ICP6 function. In this case, the identification of a difference in 
function of ICP6 between HSV1 and BV would be a novel finding in the field of herpesvirus 
research, as it has been assumed that functions of viral proteins are conserved through the 
families of herpesviruses. 
Third, we found that mTOR phosphorylation is significantly enhanced by the presence of 
B virus US3. This result is in accordance with our expected findings as US3 has been shown to 
enhance mTOR phosphorylation and activity during HSV1 infection. We also showed that this 
activation depends on the presence of p38 activity. In the absence of p38, mTOR 
phosphorylation is greatly decreased even in the presence of US3. This indicates that mTOR 
phosphorylation does require p38 activity to an extent. Lastly, we found that phosphorylation of 
4E-BP1 at serine 65 is maintained in the presence of US3; however, this is also dependent on 
p38 activity. This result was also expected as 4E-BP1 inactivation is directly affected by mTOR 
activity. Also, previous studies have shown that p38 activity does stimulate certain functions of 
mTOR, such as 4E-BP1 phosphorylation, but does not affect mTOR phosphorylation itself. 
Though these results are intriguing and may bring novel results to the fields of B virus 
research and herpesvirus research, it is pertinent that the roles of ICP6 and US3 be examined in 
the natural host cells. With transfection in the natural host cells, we will be able to answer two 
questions that could not be answered with only the CHO transfection assays: 1) How do ICP6 
and US3 behave in their natural host and 2) Are the functions discovered in CHO cells the same 
as those in macaque cells. The answers to these questions are of great importance because they 
will tell us the true nature of these proteins during infection and also, whether or not their 
function differs depending host cell. This finding could provide great insight into the difference 
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in outcome of infection between human hosts and macaque hosts and also be a big stepping stone 
in studying any zoonotic virus infection. 
We were unable to perform this last task of transfecting natural host cells as these cells 
are primary fibroblasts that are isolated by the hands of researchers in our labs. This is significant 
for two reasons. The first being that most primary cell lines used in transfection assay are 
embryonic or stem cells, which means that they are heartier and able to withstand the cytotoxic 
reagents used for lipofection. Because we isolate our fibroblasts from necropsy samples provided 
to us by another institutions, most of the samples we receive are harvested from animals that are 
at least one year old, though most of the time they are a bit older. The cell line used in these 
assays came from an animal that was approximately 4 years old at the time of necropsy. The 
second reason is that primary cell lines used in transfection assays are commercially available 
and are purchased from a company that create a homogenous cell line for optimal performance. 
Because rhesus macaque fibroblasts were not commercially available at the time these 
experiments were being conducted, we had to isolate fibroblasts ourselves using a hybrid of 
different isolation techniques to obtain optimal results. 
Lipofectamine® Transfection reagents are currently the most referenced transfection 
reagents. To date it is the most efficient versatile reagent for the widest range of cells including 
cell types that are difficult to transfect, such as primary cells (78). The fact that we were unable 
to transfect our primary rhesus macaque fibroblast cell lines using these reagents implies that the 
cells are not able to withstand the cytotoxicity of the reagents rather than the implication that the 
reagents aren’t compatible for these cells.  
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3.7 Figures 
 
Figure 10: PPM1G is not induced by B virus infection or p38 
 
Figure 10: PPM1G is not induced by B virus infection or p38. (Top) Western blot 
analysis of RMF uninfected (U), treated with mock cell lysate (M), infected with B virus at MOI 
5 (B), or infected with BV and treated with SB203580 (p38i) for 24 hours. (Bottom) 
Densitometric analysis of PPM1G normalized to the amount of GAPDH in each sample. Figures 
are representative of three independent experiments in duplicate. 
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Figure 11: Phosphorylated mTOR is not upregulated by B nor dependent on p38 
 
Figure 11: Phosphorylation of mTOR is not upregulated by B virus and is not dependent 
on p38. (Top) Western blot analysis of RMF uninfected (U), treated with mock cell lysate (M), 
infected with B virus at MOI 5 (B), or infected with BV and treated with SB203580 (p38i) for 24 
hours. (Bottom) Densitometric analysis of phospho-mTOR normalized to the amount of GAPDH 
in each sample. Figures are representative of three independent experiments in duplicate. 
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Figure 12: Verification of UL39 transfection in CHO cells 
 
Figure 12: Verification of UL39 transfection in CHO cells.Western blot analysis of CHO 
cells transfected with 2 ug or 4 ug of plasmid DNA and untranfected CHO cells. Antibodies 
against the V5 epitope in the plasmid were used to detect protein product. Figures are 
representative of two independent experiments in duplicate. 
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Figure 13: Verification of transfection and p38 inhibition in CHO cells 
 
Figure 13: Verification of transfection and simultaneous p38 inhibition in CHO cells. 
Western blot analysis of CHO cells transfected with 2 ug of UL39 plasmid DNA or 
untransfected in the presence or absence of SB203580. Antibodies against the V5 epitope in the 
plasmids and phospho-p38 were used to detect the presence of the proteins. Figures are 
representative of two independent experiments in duplicate. 
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Figure 14: ICP6 does not enhance eIF4G or eIF4E phosphorylation 
 
 
Figure 14: ICP6 does not enhance eIF4G or eIF4E phosphorylation. (Top) Western blot 
analysis of CHO cells transfected with 2 ug of UL39 plasmid DNA or untransfected in the 
presence or absence of SB203580. Antibodies against the V5 epitope in the plasmids and 
phospho-eIF4G and phosphor-eIF4E were used to detect the presence of the proteins (Bottom) 
Densitometric analysis of phospho-eIF4G and phosphor-eIF4E normalized to the amount of 
GAPDH in each sample. Figures are representative of two independent experiments in duplicate. 
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Figure 15: Verification of US3 transfection in CHO cells 
 
 
Figure 15: Verification of US3 transfection in CHO cells. Western blot analysis of CHO 
cells transfected with 4 ug or 2 ug of US3 plasmid DNA or untransfected. Antibodies against the 
V5 epitope in the plasmids were used to detect the presence of the proteins. Figures are 
representative of two independent experiments in duplicate. 
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Figure 16: Verification of US3 transfection and p38 inhibition in CHO cells 
 
Figure 16:Verification of US3 transfection and p38 inhibition in CHO cells. Western blot 
analysis of CHO cells transfected with 2 ug of US3 plasmid DNA or untransfected in the 
presence or absence of SB203580. Antibodies against the V5 epitope in the plasmids and 
phospho-p38 were used to detect the presence of the proteins. Figures are representative of two 
independent experiments in duplicate. 
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Figure 17: US3 upregulates mTOR phosphorylation in a p38-dependent manner 
 
Figure 17: B virus US3 upregulates mTOR phosphorylation in a p38-dependent manner. 
(Top) Western blot analysis of CHO cells transfected with 2 ug of US3 plasmid DNA or 
untransfected in the presence or absence of SB203580. Antibodies against the V5 epitope in the 
plasmids and phospho-mTOR were used to detect the presence of the proteins (Bottom) 
Densitometric analysis of phospho-mTOR normalized to the amount of GAPDH in each sample. 
Figures are representative of two independent experiments in duplicate. 
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Figure 18: US3 does not affect Akt activity in the presence and absence of p38 
 
 
Figure 18: US3 does not affect Akt activity in the presence and absence of p38. (Top) 
Western blot analysis of CHO cells transfected with 2 ug of US3 plasmid DNA or untransfected 
in the presence or absence of SB203580. Antibodies against the V5 epitope in the plasmids and 
phospho-Akt were used to detect the presence of the proteins (Bottom) Densitometric analysis of 
phospho-Akt normalized to the amount of GAPDH in each sample. Figures are representative of 
two independent experiments in duplicate. 
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Figure 19: US3 supports 4E-BP1 phosphorylation in a p38-dependent manner 
 
 
Figure 19:US3 supports 4E-BP1 phosphorylation in a p38-dependent manner. (Top) 
Western blot analysis of CHO cells transfected with 2 ug of US3 plasmid DNA or untransfected 
in the presence or absence of SB203580. Antibodies against the V5 epitope in the plasmids and 
phospho-4E-BP1 (S65) were used to detect the presence of the proteins (Bottom) Densitometric 
analysis of phospho-4E-BP1 (S65) normalized to the amount of GAPDH in each sample. Figures 
are representative of two independent experiments in duplicate. 
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Figure 20: Optimization of UL39 transfection in RMF 
 
Figure 20: Verification of UL39 transfection in RMF. Western blot analysis of RMF 
transfected with 8 ug, 4 ug or 2 ug of UL39 plasmid DNA. Antibodies against the V5 epitope in 
the plasmids were used to detect the presence of the proteins. Figures are representative of two 
independent experiments in duplicate. 
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Figure 21: Optimization of US3 transfection in RMF 
 
Figure 21: Verification of US3 transfection in RMF. Western blot analysis of RMF 
transfected with 8 ug, 4 ug or 2 ug of US3 plasmid DNA. Antibodies against the V5 epitope in 
the plasmids were used to detect the presence of the proteins.  
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Figure 22: Verification of transfection in RMF 
 
Figure 22: Verification of UL39 and US3 transfection in RMF. Western blot analysis of 
RMF transfected with 2 ug of UL39 or US3 pcDNA, empty vector or untransfected. Antibodies 
against the V5 epitope in the plasmids were used to detect the presence of the proteins. Figures 
are representative of two independent experiments in duplicate. 
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Figure 23: Expression of peIF4G in UL39 transfected RMF 
 
Figure 23: (Left) Western blot analysis of phosphorylated eIF4G in RMF transfected with 
2 ug of UL39 pcDNA, empty vector, or untransfected. Antibodies phospho-eIF4G were used to 
detect the presence of the proteins (Right) Densitometric analysis of phospho-eIF4G normalized 
to the amount of GAPDH in each sample.  
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Figure 24: Expression of peIF4E in UL39 transfected RMF 
 
Figure 24: (Left) Western blot analysis of phosphorylated eIF4E in RMF transfected with 
2 ug of UL39 pcDNA, empty vector, or untransfected. Antibodies phospho-eIF4E were used to 
detect the presence of the proteins (Right) Densitometric analysis of phospho-eIF4E normalized 
to the amount of GAPDH in each sample. 
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Figure 25: Expression of P-mTOR in US3 transfected RMF 
 
Figure 25: (Left) Western blot analysis of phosphorylated mTOR in RMF transfected 
with 2 ug of US3 pcDNA, empty vector, or untransfected. Antibodies phospho-mTOR were used 
to detect the presence of the proteins (Right) Densitometric analysis of phospho-mTOR 
normalized to the amount of GAPDH in each sample. 
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Figure 26: Cell death ratio of UL39 transfected RMF in the presence and absence of 
SB203580 
 
Figure 26: (Top) Trypan blue exclusion assay of RMF transfected with UL39. Cells were 
scraped into media and diluted with trypan blue. Dead cells were counted separately from live 
cells in duplicate. (Bottom) Trypan blue exclusion assay of RMF transfected with UL39 in the 
presence of SB203580. Cells were scraped into media and diluted with trypan blue. Dead cells 
were counted separately from live cells in duplicate. 
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Figure 27: Cell death ratio of US3 transfected RMF in the presence and absence of 
SB203580 
 
Figure 27: (Top) Trypan blue exclusion assay of RMF transfected with US3. Cells were 
scraped into media and diluted with trypan blue. Dead cells were counted separately from live 
cells in duplicate. (Bottom) Trypan blue exclusion assay of RMF transfected with US3 in the 
presence of SB203580. Cells were scraped into media and diluted with trypan blue. Dead cells 
were counted separately from live cells in duplicate 
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Figure 28: Cytotoxic Effects of transfection in RMF in the presence and absence of 
SB203580 
 
Figure 28: Control treated RMF and RMF transfected with empty vector in the presence 
and absence of SB203580. 
78 
 
Figure 29: Cytotoxic Effects of transfection in RMF in the presence and absence of 
SB203580 
 
Figure 29: RMF transfected with US3 (top) or UL39 (bottom) in the presence and 
absence of SB203580. 
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4 MATERIALS AND METHODS 
4.1 Cells 
Rhesus macaque fibroblasts (RMF). Because these cells were not commercially available, 
they had to be isolated from male and female genital skin. The skin segments were provided by 
Yerkes Primate Research Center, Emory University, Atlanta Georgia. The tissue was preserved 
in DMEM upon collection. For isolation, the tissue was removed from the media and prepared as 
previously described [22]. RMFs were grown in Dulbecco’s Modified Eagles Medium (DMEM) 
supplemented with 18% fetal bovine serum (FBS). These fibroblasts were used to recapitulate 
the primary site of B virus infection in macaques. Passage numbers 6-10 were used to maintain 
consistency throughout experiments. For the purposes of this dissertation these cells will be 
called RMF. 
CCD-1079Sk (ATCC® CRL-2097). Human foreskin fibroblasts were purchased from 
ATCC and grown in minimum essential medium (MEM) supplemented with 10% FBS, 0.1 mM 
non-essential amino acids, and 1.0 mM sodium pyruvate. These fibroblasts were used to 
recapitulate the primary site of B virus infection in humans.  Passage numbers 6-10 were used to 
maintain consistency throughout experiments. For the purposes of this dissertation these cells 
will be called HFF. 
Vero (ATCC® CL81). Vero (African green monkey kidney cells) were purchased from 
ATCC. They were grown in DMEM supplemented with 10% FBS. These cells were used to 
prepare infected cell lysate for virus stock as well as uninfected cell lysate. They were also used 
for plaque assay analyses.  
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CHO-K1 (ATCC® CCL-61). Chinese hamster ovarian (CHO) cells were purchased from 
ATCC. They were grown in F12K medium supplemented with 10% FBS and 1% antibiotic. 
These cells were used in B virus protein transfection assays. 
Subculture. Prior to passaging, cells were washed twice with phosphate buffered saline 
(1X PBS). Trypsin-EDTA was added and incubated at 37°C in 5% CO2 for a period of 3-5 
minutes to allow time for cells to detach from the surface of the well or flask. The trypsin was 
neutralized by adding equal amounts or more of medium containing FBS. The cells were 
resuspended and placed into new vessels. For all experiments involving plating of cells into 
wells, trypan blue was added to aliquots of cell suspension for viable cell counting and then 10 μl 
of the cell solution was loaded onto both sides of a hemocytometer. Plates were seeded equally 
and grown to sub-confluency. If remaining cells were to be stored for later use, the cell solution 
was then transferred to a sterile 15 ml conical tube and centrifuged at 1200 rpm for 5 minutes. 
The supernatants were discarded and the pellets were resuspended in freezing medium (DMEM 
with 10% DMSO (dimethyl sulfoxide) and 20% FBS). Cells were then aliquotted into sterile 
cryovials to be frozen initially at -80°C in a designated cell-freezing container. Once frozen, cells 
were transferred to liquid nitrogen for long-term storage. 
4.2 Chemicals 
The p38 inhibitor InSolution™ SB203580 (EMD Millipore, cat # 559398) was used to 
reduce phosphorylation of p38. 100X stocks were prepared in order to use the recommended 
concentration for IC50 of 600 nM in primary cells. This drug competitively binds to the ATP-
binding pocket to block phosphorylation of p38α and p38β, but not p38γ or p38δ [53]. 
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The inhibition via SB203580 relies on interaction with the amino acids near or inside of 
the ATP-binding pocket, specifically with Thr106 of p38α and p38β [53, 54]. The inhibitor and 
stocks were stored at -20°C. 
4.3 Viruses 
B virus laboratory strain E2490, passage number 74, was propagated in Vero cells and 
stock was prepared by lysing infected cells through 1-2 rounds of rapid freeze/thaws followed by 
storage in -80°C. All infections with virus were performed under Bio Safety Level (BSL) – 4 
conditions in a registered facility in accordance with the Biosafety in Microbiological and 
Biomedical Laboratories (BMBL) manual, 5th Edition.  
For the purpose of infections, HFF and RMF were counted and seeded into 24 well plates 
at a desired density that would allow them to reach 90% confluency in 2-3 days. The multiplicity 
of infection (MOI) used was MOI 5. Mock cell lysate (MCL) was prepared with lysed Vero cells 
and was used as a control treatment to represent the environment the cells were exposed to 
during infection, but without the presence of virus. MCL was collected at the same time and in 
the same way as B virus stock. Virus and MCL were diluted in Hank’s Buffered Salt Solution 
(HBSS) for the appropriate MOI. 
For kinetic experiments, media was removed and kept in sterile 50 ml conical tubes for 
the respective cell lines and will be referred to as ‘spent media’. Cells were then washed with 1X 
PBS twice and then 200 μl of virus solution was added to each well. The plates were then placed 
in the incubator at 37°C with 5% CO2 for 1 hour, known as the absorption period. After the 
absorption period, virus was removed and replaced with 500 μl of spent media for the respective 
cell type. Samples were collected at various times through 24 hours post infection. MCL solution 
was prepared to the same MOI and administered to cells in the same manner.  
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For inhibition experiments, much of the same procedure is followed with the addition of 
serum starvation 12-18 hours prior to infection. Cells were pre-treated with SB203580 for 1 hour 
diluted in either MEM or DMEM, depending on cell type on the day of infection. Before 
infection, the pre-treatment was removed and the cells were washed twice with 1X PBS. The 
virus solution was prepared with the specified amount of SB203580 and 200 μl of virus solution 
in the presence of SB203580 was applied to designated wells. The plates were then incubated in 
37°C in 5% CO2 for the absorption period. Virus or MCL was removed and replaced with 
maintenance medium (MEM/DMEM, 2%FBS, 1% antibiotic) either with or without SB203580. 
The plates were placed back in incubation for 24 hours, after which the samples were collected. 
4.4 SDS-PAGE and Western blot 
After infection or MCL treatment, total cell lysates were collected using 75 l of 
Laemmli Buffer with protease/phosphatase inhibitor per well. The samples were then stored at -
20°C.  Each sample was collected in duplicate. Acrylamide gels containing 10% SDS were 
prepared to analyze protein phosphorylation and expression. The samples were heated at 99°C 
for 5 minutes to denature the proteins and then immediately placed on ice until they reached 
room temperature. Samples were loaded into the stacking gel portion of the gel at 15-20 l of 
sample per well. The samples were fractionated using electrophoresis for approximately 2 hours 
at 91V. Proteins present within the gel were then transferred to nitrocellulose membranes for 
approximately 2 hours at 71V, or overnight at 22V. The membranes were stained with Ponceau S 
stain to ensure a successful transfer took place. The stain was washed off with 0.1M NaOH for 
30 seconds, followed by washes with water two times for 5 minutes each. Blotto (5% non-fat dry 
milk, 1X TBS, 0.1% Tween 20) was applied to the membranes and they were incubated at room 
temperature on a rocker for 1 hour. When using one membrane to look at multiple proteins, 
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sometimes the membranes were cut based on the molecular weights of the proteins to maximize 
the use of the samples. A dual color ladder marker was used to delineate where the cuts should 
be made and this was done prior to washing off the Ponceau S stain. After the 1 hour blocking 
period, the blotto was washed from the membranes using Tris-buffered Saline with Tween-20 
(TBS-T) for 10 minutes three times. After each wash, the TBS-T was discarded and fresh TBS-T 
was used for the next wash. After the three washes the primary antibodies were prepared in 
primary antibody buffer (5% w/v BSA, 1XTBS, 0.1% Tween®20) to detect phospho-p38 (Cell 
Signaling Technology, cat #4511), phospho-4EBP-1 (Ser65) (Cell Signaling Technology, cat # 
9456), phospho-p44/42 MAPK (ERK1/2) (Cell Signaling Technology, cat #4370) and phospho-
eIF4E (Ser209) (Abcam, cat # ab76256) and incubated in 4°C overnight. The following day, the 
primary antibodies were removed and stored in 4°C if used once and discarded if used twice. The 
membranes were washed three times for 10 minutes with TBS-T, with new TBS-T used for each 
wash. Anti-rabbit IgG secondary antibody was prepared according to the manufacturer’s 
instructions and applied to the membranes, which then incubated for 1 hour at room temperature. 
At the end of 1 hour, the secondary antibody was removed and again membranes were washed 
three times for 10 minutes with new TBS-T for each wash. At the end of the third wash, 
membranes were placed in fresh TBS-T in their containers and taken to the core facility provided 
by the Biology department of Georgia State University, Atlanta Georgia and proteins were 
imaged by the LAS4000 mini by GE Healthcare. The membranes were blotted to removed 
excess TBST-T and then placed in a clear plastic sheet. Enhanced Chemiluminescence (ECL) 
solution from GE Healthcare was prepared according to the manufacturer’s instruction and 
applied, dropwise to the membranes at 1 ml per membrane. A clear plastic cover was applied 
over the membrane and air bubbles under the cover were eliminated and the membrane was 
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placed in the machine. The exposure process was done in increments of 1 minute for 5 minutes 
and the best exposure that was clear but not over developed was chosen for further analysis. 
ImageQuant software was used to process the image to determine band densities for quantitative 
analysis. Experimental sample values were then normalized to control samples. Statistics were 
done using Prism6 by GraphPad Software, Inc. 
4.5 Plaque Assay 
After infections in the inhibition assays, samples were collected by scraping the bottom 
of the wells into the medium and collecting the solution into a 1.5 micro-centrifuge tube with an 
O-ring closure cap. Each sample was collected in duplicate. These samples were stored at -80°C 
for future use. Veros were seeded into 24 well plates at a desired density to reach approximately 
90% confluency in 2-3 days. On the day of infection, serial dilutions (10-1 to 10-4) of previously 
collected samples were made in 1 ml of HBSS. The 10-1 dilution was discarded. For infection 
200 l of the serial dilutions were applied to each well in duplicates. The plates were incubated 
at 37°C in 5% CO2 for an absorption period. Unabsorbed virus was removed and 1% 
methylcellulose supplemented with 2% FBS was applied to each well. The plates were placed in 
the incubator for 48 hours. The methylcellulose was removed and the wells washed twice with 
1X PBS to remove residual methylcellulose. The cells were fixed with 100% methanol for 15 
minutes. Once the plates were dried, the wells were stained with crystal violet and plaques were 
observed under microscope and counted to determine plaque forming units (PFU). 
4.6 Transfection Assays 
pcDNA vectors from Invitrogen® were excised and B virus genes UL39 and US3 were 
each inserted into the sequence. These plasmids were a gracious gift from Dr. Irina Patrusheva. 
CHO cells were seeded into two 24 well plates and grown to approximately 70% confluency. 
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Culture medium was discarded and the cells were washed one time with 1X PBS. Transfection 
medium consisting of Opti-MEM® with 1% FBS was added to the wells. Lipofectamine 3000® 
reagents were used according to the manufacturer’s protocol [78]. Initially two micrograms and 
four micrograms of plasmid DNA were transfected into cells to optimize the amount of DNA 
needed for subsequent experiments. After 48 hours, the medium was discarded and the cells were 
gently washed with 1X PBS. Laemmli buffer was used to collect whole cell lysate for analysis. 
For the transfection and simultaneous inhibition assay, the same protocol was followed 
for transfection with a pre-treatment of cells for 1 hour with SB203580 prior to the transfection. 
In transfection medium, SB203580 was added at an IC50 of 600 nM. The cells were collected 
after 24 hours with Laemmli buffer. 
For transfection of RMF, the times post transfection were extended to 48 hours in the 
case of UL39 transfected cells and 72 hours in the case of US3 transfected cells. 
4.7 Trypan Blue Exclusion Assay 
RMF were transfected according to transfection assay indicated above. On the days of 
collection, cells were imaged microscopically and then scraped with a pipette tip into the 
medium. Thirty microliters of cell solution was transferred to an Eppendorf tube with 30 ul of 
trypan blue. Ten microliters were loaded onto both sides of a hematocytometer and the number 
of dead cells (stained blue due disruption of membrane integrity) and the number of live cells 
(unstained due to intact membrane) were counted separately in duplicate for each sample. 
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5 CONCLUSIONS 
5.1 Understanding zoonotic viruses: what we know about their behaviors in natural vs. 
foreign hosts 
New infectious diseases are emerging every year and have an immense impact on human 
health [80]. Most infectious diseases are caused by viruses, the majority of which originated in 
an animal species including Ebola, HIV, hantaviruses, Hendra and Nipah viruses, severe acute 
respiratory syndrome (SARS), coronavirus, and influenza A viruses [81, 82]. Transmission of 
these zoonotic viruses varies and with the growth in size and mobility of human populations, 
environmental changes, and spread of agricultural practices that promote more contact with 
animals, the frequency of exposure to these pathogens and dissemination has greatly increased 
[83]. Tools developed to quickly detect these viruses have been improved in recent years leading 
to more rapid detection and diagnosis in humans as well as rapid identification of reservoir hosts 
[84, 85]. The introduction and spread of these pathogens in foreign host populations is a popular 
topic of research [86, 87], but host-dependent responses triggered by host-virus interactions are 
still poorly understood. These host-virus interactions are critical in determining the outcome of 
infection and the likelihood of transmission. 
In the natural hosts, these viruses have little to no effect on the individual animal or the 
species population as a whole due in part to the theory that these viruses have co-evolved with 
their respective hosts for thousands of years and have developed a tolerant synergy with one 
another. The co-evolutionary relationship between a virus and its natural host is such that the 
body of the natural host responds to the presence of the virus with little to no significant physical 
symptoms and the virus is permitted to replicate within the host cell and be disseminated through 
the route of transmission used with little to no issue. In foreign hosts, infection with these viruses 
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can result in fatal disease while causing only mild infections in their natural hosts. Different 
zoonotic viruses affecting humans can be characterized by unique biological and clinical 
manifestations. These manifestations in humans are complex and poorly understood. The first 
step in establishment of a new host species for a virus is the manipulation of intercellular 
interactions between the virus and the host. Modification of various signaling pathways within 
the infected cell of the new host is crucial for establishing the tolerant synergy a virus has with 
its natural host, therefore signaling pathways are one of the first targets of virus control and 
manipulation. Determining what, if any, effectors may impact viral replication kinetics within 
the natural vs. foreign hosts may provide valuable information about why some viruses cause 
severe disease in humans. Assessing possible effectors, such as stress response pathways, has 
become a hot topic of research in regards to determining the difference in outcomes of infection 
in zoonotic viruses. 
5.2 The role of MAPK p38 stress response pathway in viral infection of susceptible hosts 
The MAPK signaling cascades are involved in many cellular activities such as gene 
expression, cell-cycle regulation, metabolism, motility, survival, and apoptosis. Among the 
MAPKs, the ERKs, JNKs, and p38 MAPKs are the most studied [88, 89]. Canonically, ERKs are 
usually activated in response to mitogens like growth factors and phorbol esters, and the JNKs 
and p38 MAPKs are responsive to stressful stimuli like osmotic shock, cytokine stimulation, and 
infection [90]. The p38 MAPK is strongly activated by various physical and chemical stresses 
like oxidative stress, ultraviolet irradiation, hypoxia, ischemia and cytokines. The p38 stress 
response plays a role in apoptosis, differentiation, proliferation and inflammation and there is a 
substantial amount of evidence indicating that p38 activity is critical for normal immune 
function. The p38 MAPK pathway has been implicated as having a role in multiple pathologies 
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such as inflammation, cancer and virus infection and is highly conserved between species. 
Cytokine production has been shown to be mediated by p38α in mice [91]. Pro-inflammatory 
cytokine (PIC) production is a major stimulant of chronic inflammatory and rheumatic diseases 
such as rheumatoid arthritis and Crohn’s disease and there is evidence that PIC also plays a role 
in heart failure and ischaemic retinopathies [92, 93]. Blocking the production of PIC has become 
an attractive therapeutic strategy and a number of pharmaceutical companies have been 
developing drugs targeting p38α to block PIC production, some of which have advanced to 
human clinical trials such as AMG 548 (Amgen) and SCIO 323(Scios, Johnson and Johnson) 
[94]. Recently it has been shown that inhibition of p38 impairs influenza virus-induced host 
responses in mice. Avian influenza viruses can be highly pathogenic and induce severe 
inflammatory reactions in birds and humans. One characteristic of these viruses is the induction 
of cytokines that enhance viral pathogenesis. This enhancement appears to involve the 
hyperactivation of p38 during infection. Influenza A virus activates all four of the know MAPK 
cascades. It was observed that p38 has an important role in highly pathogenic avian influenza 
virus (HPAIV)-induced cytokine and chemokine dysregulation, therefore making it a new 
possible target for antiviral therapy for influenza viruses. This study also implicated a role for 
p38 in recruitment of immune cells during an influenza infection by regulating chemotactic 
cytokines such as CXCL9, -10, -11, and CCL5 in endothelial cells [95]. The role of p38 in viral 
infection and pathogenesis is still being investigated and its role may differ depending on the 
type of virus and the infected host, but it is clear that the p38 stress response plays a pivotal role 
in host-virus interactions. It is for this reason that we investigated the effect of p38 on B virus 
infection in the natural and foreign hosts. 
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We selected the MAPK p38 stress pathway to study its function during zoonotic viral 
invasion, using a cell-based model of species-specific infection. In the absence of adequate 
animal models to study zoonotic infection and the costly in vivo studies in the natural host of B 
virus, we established a cell model system to investigate potential differences that may exist in the 
natural versus the human host cells targeted upon virus entry. The use of this cell model system 
allows the use of many essential controls and the isolation of specific innate defense pathways. 
The particular interest for this dissertation research was to enhance our understanding of cell 
translational machinery and how the use of such machinery may differ between hosts and in the 
presence or absence of virus infection, thus we focused our studies on the translation factor 
eIF4E, which is crucial to cap-dependent translation, and additionally on 4E-BP1, one of the 
critical regulators of eIF4E in addition to p38 and ERK. To better understand the use of 
translation machinery by the two cell species chosen for this research in the context of virus 
infection, we must first understand the co-evolution of B virus with macaques and other 
herpesviruses with their respective hosts. 
5.3 The co-evolution of herpesviruses and their hosts 
The first step in understanding why a virus is relatively harmless in its natural host, but 
devastating in a foreign host is to first understand what is occurring in the natural host. 
Herpesviruses belonging to the genus Simplex are, for the most part, species-specific. Almost 
every species of animal has a herpesvirus that has co-evolved with it and the herpesvirus is 
specific for that particular species. This trait of species restriction that is a characteristic of most 
simplex viruses is a product of virus-host interactions being selected for to allow peaceful co-
existence. As with most things, there are exceptions to every rule. Herpes B virus, though 
endemic in macaque monkeys, is capable of infecting human hosts. Currently there is only one 
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reported case of human to human spread of B virus, indicating that the virus is less efficient at 
transmission within its human host. The human herpes simplex viruses type 1 and 2 may at one 
point been zoonotic infections that were able to take hold within the human population and 
establish a co-evolutionary relationship, though which human herpes virus infected humans first 
is still a topic of debate. Many viruses that humans are familiar with today such as the influenza 
viruses and the human immunodeficiency virus (HIV) are products of zoonotic viruses that 
successfully jumped the species barrier and are just as effective if not more so in their human 
hosts. The first step in jumping the species barrier is to alter these virus-host interactions to suit 
the virus within its new host. From there, the virus can start to spread itself first among a small 
population of its new host and eventually spread to larger populations and either reach an 
epidemic status or become endemic wherein the virus will evolve to co-exist within that new 
host population. Regardless of the severity of infection from a zoonotic host and the amount of 
time it takes to settle within a new host population, it always begins with altering the interactions 
within the cell to the virus. 
5.4 Regulation of MAPK p38 pathway during B virus infection 
The first sight of infection for B virus, before the virus enters the sensory neurons, is the 
skin. The skin is an essential barrier to infection and it contains many layers, one of which is the 
dermis that houses fibroblast cells. Fibroblasts are important contributors to innate immunity 
functions in the skin and are capable of secreting a variety of cytokines, chemokines, and 
antimicrobial peptides. With our cell culture model that represents the cells that would first 
become infected at a primary site of infection in both macaques and humans, we can investigate 
the initial events following B virus infection and how these events affect downstream factors. 
The p38 MAPK pathway, which leads to cytokine secretion and apoptosis is a crucial event that 
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is triggered by infection with B virus. The natural and foreign host cell model has allowed us to 
analyze this pathway in both cell types infected with B virus and observe any host-dependent 
events that may occur.  Of the four known MAPKs, p38 and JNK are triggered by stressful 
stimuli as opposed to the others that are stimulated by non-threatening mitogens. During B virus 
infection and other virus infections, p38 is activated presumably to trigger a cytokine and cellular 
defense response. Though other MAPKs such as the ERKs may initially be activated, ERK 
activity is eventually downregulated by viruses. Though the activation of p38 is undoubtedly to 
help the host, the activation of this pathway can also be harmful if not regulated properly as is 
evidenced in the case of avian influenza studies [95]. The overstimulation of this pathway can 
lead to prolonged pro-inflammatory cytokines, which can also be harmful to the hosts in addition 
to the infection the cells are attempting to fight. Our studies indicate that there may be a host-
dependent regulation of the p38 MAPK stress response pathway in regards to B virus infection.  
In the natural host, p38 activity is increased during infection and translation is initiated. 
This indicates that the cells are activating the pathway to fight the infection. The increase in 
activity is most apparent at 24 hours post infection, which is after the virus has completed at least 
one round of successful replication. Activation of translation initiation factor eIF4E is also 
observed, though a significant increase does not occur. Our data suggest that although B virus 
infection of human cells targeted at virus entry does not significantly impact eIF4E 
phosphorylation to enhance or decrease mRNA translation via the MAPK p38 pathway, macaque 
cells may effectively use this pathway to limit virus replication to levels that can be controlled by 
host defenses. This indicates that, although the cell is infected with a virus, the cell is tolerating 
the infection to an extent. There appears to be a balance struck between the natural host cell and 
the virus to protect the host, yet still allows successful virus replication. This is the first evidence 
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of host-dependent response to B virus infection in the context of cellular translation indicating 
that if a divergence between hosts was in affect during infection, it involves manipulation of 
cellular translation machinery.  Cellular translation at this point may be utilized by the cell to 
translate proteins to aid in cellular defense or by the virus to produce viral proteins.  
Because 4E-BP1 hyperphosphorylation was identified as a critical mechanism which 
HSV1 and human hosts selected during their co-evolution, we asked whether this particular 
aspect of infection was conserved between B virus and its natural host, macaques. When p38 
activity is inhibited, this leads to a decrease in inactive 4E-BP1, which should also lead to a 
decrease in eIF4E activation and translation, but does not implicating a role of p38 in regulation 
of 4E-BP1 phosphorylation. This observation suggested that there should be more 
hypophosphorylated 4E-BP1, but when expression levels were analyzed it was observed that 
there was no change in hypophosphorylated 4E-BP1 when p38 activity was inhibited.  To 
determine what caused the decrease in hyperphosphorylated 4E-BP1, we analyzed the expression 
pattern of the positive regulator, PPM1G, and the negative regulator, mTOR, of 4E-BP1 and 
discovered that neither were significantly upregulated or down-regulated in the absence of p38; 
however, a recent publication has determined that the presence of p38 can enhance activation of 
downstream effectors of mTOR. Together, these data suggest that although p38 does not directly 
cause the decrease in hyperphosphorylated 4E-BP1, in the absence of p38 mTOR is not 
stimulated to phosphorylate 4E-BP1. The finding that 4E-BP1 hyperphosphorylation and 
inactivation is modulated by B virus infection in both hosts, but is only regulated by the presence 
of p38 phosphorylation in macaques further indicates that the manipulation of the p38 pathway 
and cellular translation is being targeted by B virus in an effort to establish successful infection 
of the new host. It was further determined that although p38 may play a role in eIF4E 
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phosphorylation during infection, it is not necessary for eIF4E activation. This was evidenced by 
our investigation of the effect of p38 on virus titers in the natural and foreign hosts.  
We observed a significant increase in B virus titers despite a decrease in inactive 4E-BP1. 
After further investigation it was determined that there was not more active 4E-BP1 in inhibited 
cells, but rather that there was less phosphorylation of 4E-BP1 occurring due to the indirect 
regulation of mTOR by amino acids that require basal activity levels of p38 [77]. Our data 
suggests that p38 plays a regulatory role in B virus replication in the natural host. In the absence 
of p38 activity, there is almost a log increase in virus titers. 
MAPK p38 appears to play a pivotal role in the balance between natural host survival and 
B virus infection, but has not adapted the same role in the foreign host. In human fibroblasts, 
little is changed when p38 activity is inhibited. Activation of eIF4E still occurs, but is not 
significantly upregulated or downregulated as is the case with macaque fibroblasts as well. 
Activation of eIF4E is known to be triggered by other proteins such as ERK, the MAPK 
responsive to non-stressful events; however, ERK was shown to be downregulated during B 
virus infection in both hosts indicating that it plays no role in the activation of eIF4E during B 
virus infection. Still others have hypothesized that protein kinase C (PKC) is capable of 
phosphorylated eIF4E directly in vitro, but the mechanism of action in vivo is not known [96]; 
however, this occurrence has only been observed once to date and has been disputed by several 
other sources. It is possible though that PKC along with PKA may stimulate eIF4E 
phosphorylation indirectly by activating pathways that phosphorylate MNK1, which in turn 
phosphorylates eIF4E [97, 98]. Hyperphosphorylation and inactivation of 4E-BP1 in human 
fibroblasts is increased in response to B virus infection as is observed in macaques, but is not 
decreased when p38 activity is inhibited indicating that in humans p38 does not have a 
94 
regulatory effect on 4E-BP1 in the context of B virus infection. When p38 activity is inhibited 
viral titers remain the same as seen in B virus infected cells when p38 is active. This implies that 
p38 plays a role in virus regulation in the natural host but not a significant role in the foreign 
host. Two possibilities surface when we consider this. First, that the virus may not be able to 
manipulate p38 in the human host yet or, perhaps more likely, p38 in humans hasn’t developed 
capabilities to manage B virus. 
5.5 A novel role for B virus ICP6 
Several independent investigators have provided evidence that certain specific viral 
proteins have the ability to control translation machinery or mimic the machinery. For example, 
HSV1 viral proteins have been shown to manipulate formation of the eIF4F complex [29], and 
hantavirus provides a protein that mimics the complex to enhance viral mRNA translation [30]. 
Therefore it is possible that like HSV1, a B virus protein can interfere with one or both of these 
processes involving eIF4E. 
The effect of viral proteins on cellular translational machinery is well documented. As 
stated earlier, other viruses such as HSV1 and hantavirus can manipulate or mimic this function 
to enhance viral mRNA translation. Because p38 plays an important role in regulating viral 
replication in the natural host, it was important to analyze the effect of viral proteins on macaque 
fibroblasts in the presence or absence of p38 activity. When cells are transfected with B virus 
ICP6, it is expected that there will be an increase in eIF4G activity and eIF4E activity as is the 
case with HSV-1 ICP6. Our data shows that there is no significant upregulation of either and 
further, that eIF4E and eIF4G regulation is independent of p38 activity both in the presence and 
absence of ICP6. One possible reason for this unexpected result is that, because CHO cells are 
not the natural host for this virus, the viral proteins may behave differently in CHO cells than 
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they behave in the RMFs. The second possibility is that B virus ICP6 function differs from that 
of its counterpart in HSV1. Despite the fact that HSV1, HSV2, and BV are genetically similar, 
the protein product of gene UL39 is only 77% similar between B virus and HSV1 and 78% 
similar between B virus and HSV2. This indicates that the proteins may be different enough from 
one another between the viruses that they may have different functions altogether. It is possible 
that although UL39 is confirmed to produce a ribonucleotide reductase in HSV1 and HSV2 and 
is purported to prodcue a ribonucleotide reductase in B virus, the protein itself may also have 
different functions in addition to the main function and these secondary functions may differ 
between viruses. In this case, the identification of a difference in function of ICP6 between 
HSV1 and BV would be a novel finding in the field of herpesvirus research, as it has been 
assumed that functions of viral proteins are conserved through the families of herpesviruses. 
 A side-by-side analysis of the protein product of UL39 between HSV1, HSV2, and B 
virus is necessary to determine the various functions of this conserved protein and whether these 
proteins perform different functions dependent upon the virus to which it belongs. 
5.6 A novel role for B virus US3 
Another candidate viral protein for cellular translational regulation was US3, a kinase 
encoded by the herpesvirus genome. In US3 transfected cells, we see an upregulation of mTOR 
as is also seen with HSV1 US3. This is followed by a subsequent increase in 
hyperphosphorylation of 4E-BP1. This is reflective of what we see in the natural host cells 
infected with B virus. When p38 activity is ablated, there is a decrease of mTOR activity and 
hyperphosphorylation of 4E-BP1 decreases when US3 is present, which also correlates with our 
data in the natural host. The phosphorylation of mTOR is significantly enhanced by the presence 
of B virus US3. This result reflects our expected findings as US3 has been shown to enhance 
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mTOR phosphorylation and activity during HSV1 infection. We also showed that this activation 
depends on the presence of p38 activity. In the absence of p38, mTOR phosphorylation is greatly 
decreased even in the presence of US3. This indicates that mTOR phosphorylation does require 
p38 activity to an extent. Lastly, we found that phosphorylation of 4E-BP1 at serine 65 is 
maintained in the presence of US3; however, this is also dependent on p38 activity. This result 
was also expected as 4E-BP1 inactivation is directly affected by mTOR activity. Also, previous 
studies have shown that p38 activity does stimulate certain functions of mTOR, such as 4E-BP1 
phosphorylation, but does not affect mTOR phosphorylation itself. The similarity of US3 
between B virus and HSV1 and 2 is low, despite the appearance of similar functionality of the 
protein between viruses. These results in regards to B virus proteins ICP6 and US3 are intriguing 
and may bring novel findings to the fields of B virus and herpesvirus research, but it is pertinent 
that the roles of ICP6 and US3 be examined in the natural host cells. Transfection of RMF using 
lipofection was not achieved due to high cytotoxicity of lipfection reagents. These cells are 
primary fibroblasts that are considerably older than other primary cell lines that have 
successfully been transfected using lipofection techniques. Lipofection is currently one of the 
most popular methods of transfection and has been indicated as the method of choice for difficult 
cell types such as primary cells; however, our data shows that reagents used in lipofection are 
significantly harmful to these cells and result in anywhere from 70-95% cell death in cells 
exposed to the reagents. Viral protein product is detected via the V5 epitope located in the 
pcDNA plasmids, but the reagents are so cytotoxic that any effect caused by the presence of the 
viral proteins is masked by the damage done to the cells. Taken all together, this work indicates 
that p38 does play a substantial role in both the cellular and viral workings within the natural 
host. This novel identification of the role of p38 during B virus infection in its natural host along 
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with the data that shows this role is host-dependent will be extremely helpful in identifying why 
B virus is so deadly in a foreign host but has managed to co-exist relatively peacefully with its 
natural host. 
The findings outlined in this dissertation lay crucial ground work in determining how this 
zoonotic virus regulates cellular pathways differentially between hosts, which is the first step in 
successful zoonotic transmission of a virus to a new host. These data demonstrate how a zoonotic 
virus, in this case B virus, can regulate a cellular process in the natural host with which it has co-
evolved, but not in the foreign human host and suggest how these interactions can contribute to 
the host-specific differences in the outcome of virus infection. Once it is known how a zoonotic 
virus interacts with its natural host cell and its human host cells, we will then have the possibility 
of designing intelligent antiviral therapeutics and vaccines. 
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